Professional Documents
Culture Documents
Biomolecular Chemistry
View Article Online
PAPER View Journal | View Issue
Cyclomarins are cyclic heptapeptides containing four unusual amino acids. New synthetic protocols
toward their synthesis have been developed, leading to the synthesis and biological evaluation of three
Received 14th April 2016, natural occurring cyclomarins. Interestingly, cyclomarins address two completely different targets: Clp C1,
Accepted 19th May 2016
a subunit of the caseinolytic protease of Mycobacterium tuberculosis (MTB), as well as PfAp3Ase of Plas-
DOI: 10.1039/c6ob00800c modium falciparum. Therefore, cyclomarins are interesting lead structures for the development of drugs
www.rsc.org/obc against tuberculosis and malaria.
6036 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
bacteria replicating in culture broth as well as in human- have powerful tools in hand to get access to the different
derived macrophages and a series of multidrug resistant clini- stereoisomers. While anti-configured amino acids can easily
cal isolates. Detailed studies at Novartis indicate, that ClpC1, a be obtained via allylic alkylations,27 the corresponding syn-
subunit of a caseinolytic protease, is the actual target of products are accessible via chelate enolate Claisen rearrange-
CycA.12 Very recently, the same group at Novartis reported also ment.30 Using this approach, the two stereogenic centres can
a strong activity against Plasmodium falciparum, inhibiting the easily be introduced by using a chiral allyl alcohol. Unfortu-
PfAp3Aase of the protozoan parasite, in a nanomolar range nately, the dimethylated unsaturated side chain cannot be
without affecting the human homolog hFHIT.13 Therefore, not introduced directly in a stereoselective fashion, since the
only from a synthetic view but also from a pharmaceutic/ corresponding tertiary alcohol would be achiral. To circumvent
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
medicinal point of view a synthetic protocol toward the cyclo- this problem we decided to generate a monomethyl-substi-
marins is highly desired. tuted amino acid and to introduce the dimethyl group via oxi-
The cyclomarins are cyclic heptapeptides containing two dative cleavage and subsequent olefination, as reported
proteingenic amino acids [(S)-Ala, (S)-Val)], an N-methylated previously be Yao et al.28 (Scheme 1).
(S)-Leu, as well as four unusual (S)-amino acids. Two of them We started the synthesis with an enzymatic kinetic resolu-
are also found in other natural products. δ-Hydroxyleucine tion of secondary alcohol 1, using novozyme 435. The reaction
(HyLeu) is a building block in depsipeptides isolated from was monitored by GC. Since the remaining (desired)
Paecilomyces lilacinus and Bipolaris zeicola,14 while β-methoxy- (S)-alcohol 1 and the (R)-acetate are relatively volatile com-
phenylalanine (MePhe) is also found in the discokiodines.15 pounds, which cannot be separated by distillation, we decided
The two remaining amino acids 2-amino-3,5-dimethylhex-4- to couple the remaining allyl alcohol directly with Boc-glycine
enoic acid (ADHA) and N-(1,1-dimethyl-2,5-epoxypropyl)- and to separate and purify the desired allyl ester (S)-2
β-hydroxytryptophan (DEHT) [or N-(1,1-dimethyl-2-propenyl)- (Scheme 2), which was obtained in enantiopure form. Ester 2
β-hydroxytryptophan (DPHT), respectively] are unique and only was subsequently subjected to a chelate enolate Claisen
found in the cyclomarins, although similar N-prenylated rearrangement giving rise to the γ,δ-unsaturated amino acid
tryptophans have also been observed in the ilamycins.16 It with perfect chirality transfer and excellent diastereo-
should be mentioned, that a few years ago a closely related selectivity.30 The free acid was directly converted into the
cyclic peptide M 10709 was isolated from a clinical streptomy- methyl ester 3. According to Yao28 we subjected 3 to an ozono-
cete, where the ADHA is replaced by a Val.17 lysis using a reductive workup, and the aldehyde formed was
So far, all SAR studies have been carried out with cyclo- subjected to a Wittig reaction. This sequence was found not to
marin A, obtained by fermentation, and semisynthetic deriva-
tives obtained from it.11a Interestingly, the epoxide
functionality in CycA is not responsible for the biological
activity, at least not against MTB, while the OH group of
HyLeu is. Nothing is known so far about the importance of the
β-OH group of the tryptophan.
With respect to the interesting biological activities of the
Scheme 1 Retrosynthesis of protected ADHA.
cyclomarins it is not surprising that a series of synthetic
studies have been carried out towards the unusual building
blocks,18 especially those found also in other natural
products.19–22 Our group is also involved in the development of
new synthetic methods towards such unusual amino acids23
using chelated glycine ester enolates as nucleophiles,24 which
can be used in a wide range of reactions, such as aldol reac-
tions,25 Michael additions26 or allylic alkylations.27 So far, only
one synthesis of the minor metabolite CycC has been reported,28
and our group communicated very recently the first total syn-
thesis of CycA.29 Herein, we report detailed synthesis of the
cyclomarins A, C and D, details of the synthesis of the building
blocks as well as biological data of these three natural products.
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6037
View Article Online
6038 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
(Scheme 6). After silylation of the primary OH-functionality serine-derived aldehyde 21.37 This aldehyde can also be
(15)34 a Dibal-H reduction of the ester provided the corres- obtained via Dibal-H reduction of protected serine ester, and
ponding aldehyde. Also this aldehyde was extremely sensitive should be directly used without purification to avoid racemiza-
and configurationally labile, and was therefore directly tion (Scheme 7). First, we used phenylmagnesium bromide
coupled with phosphonoglycinates 16 according to Schmidt (3 equiv.) as nucleophile, giving rise to the desired aldol
et al.35 Since the protecting group of the dehydroamino acid product in acceptable yield (60%) but only moderate diastereo-
has a strong influence on the selectivity of the subsequent selectivity (dr 7 : 3). Much better results were obtained after
asymmetric hydrogenation, and good results are generally transmetallation to titanium. Although a large excess of the
obtained with N-acetyl derivatives, we used this protecting titanium reagent, prepared in situ, was required for good yield,
group also in the phosphonoglycinate (16a). But in our case the desired product 22 was obtained as a single diastereomer.
the olefination with this reagent was rather sluggish, and an Its configuration was determined by deprotonating with NaH
epimerization of the α-chiral aldehyde could not be sup- and formation of oxazolidinone 23. Coupling constants of J =
pressed. In addition, the yield of 17a was rather low. Neverthe- 4.9 Hz for the two ring protons are typical for trans-configured
less, we subjected this dehydroamino acid to a catalytic oxazolidinones.38 The formation of the syn-configured
hydrogenation using (R)-monophos as a chiral ligand.36 At 20 addition product 22 can be explained via the chelate Cram-
bar hydrogen pressure, the hydrogenation was complete after model.39 The methylation of the β-OH group in 22 was by far
3 h and the desired amino acid 18a was obtained in good yield not as trivial as it looks like at first sight. Typical reaction con-
and high ee, but as a 3 : 1 diastereomeric mixture (4R : 4S) (as ditions such as Ag2O/MeI or pyridine/MeOTf did not lead to
the result of the aldehyde epimerisation). significant amounts of methylated product 24, even not after
Therefore, we investigated olefinations using other pro- 3 d of reaction time. But if 22 was deprotonated with an excess
tected phosphonoglycinates. With the Cbz-protected phos- of LHMDS in DMF, the methylation with MeI was complete
phonate 16b the condensation with the fresh prepared after only 10 min at −10 °C. Subsequently, the silyl ether was
aldehyde proceeded cleanly at −78 °C, and the desired dehy- cleaved and the primary alcohol was oxidised to acid 25 in
droamino acid 17b could be obtained in almost enantiomeri- quantitative yield.
cally pure form in good overall yield. Luckily, the ee-value in Protected β-hydroxytryptophans. Most efforts had to be dedi-
the hydrogenation step was comparable to the acetyl derivative cated to the synthesis of the tryptophan building blocks, not
and only 5% of the wrong diastereomer (2S,4S) was observed. only because of the high acid-sensitivity of the β-OH group,
To finalize the synthesis of the required building block 20, 18b but also of the terminal double bond of the reverse prenyl
group. When we started our investigations, only one protocol
was known for the introduction of the tert-prenyl group,
Scheme 6 Synthesis of protected N-Me-HyLeu 20. Scheme 7 Synthesis of protected MePhe 25.
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6039
View Article Online
6040 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6041
View Article Online
6042 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
was also used for the next coupling step. For the synthesis of
cyclomarin C the tetrapeptide was reacted with N-methylated
amino acid 20, while 19 was used for cyclomarin
D. Hydrogenolytic removal of the Cbz-protecting groups from
the heptapeptides proceeded smoothly and tert-prenylated
tryptophan 40 was coupled using again BEP in case of the
N-methyl derivative and EDC/HOBT for the non methylated
derivative. The N-terminal Alloc-protecting group was removed
using Pd-catalysis, using TPPTS [tri-(sodium-metasulfonato-
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6043
View Article Online
not essential for the activity towards Mycobacterium tuberculosis. (6.30 mL, 74.8 mmol) in THF (500 mL) DMAP (9.16 g,
This is in good agreement with observations made by the 75.0 mmol) and DCC (18.6 g, 90.0 mmol) were added at room
Novartis group investigating derivatives of cyclomarin A result- temperature. The reaction mixture was heated to reflux for
ing from epoxide opening reactions.11a Cyclomarin D proved 18 h. Half of the solvent was removed in vacuo and the solution
to be less active, showing a MIC in the range of 8–32 µM. was filtrated after cooling to room temperature. The filtrate
was completely evaporated and the residue was dissolved in di-
chloromethane (20 mL). The solution was washed with 1 N
Conclusions KHSO4 and dried over Na2SO4. The resulting ester (11.2 g,
48.9 mmol, 65%) was obtained as a white crystalline solid,
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
In conclusion, we have shown that the unusual amino acids of melting point: 95–98 °C. Rf (6): 0.23 (ethyl acetate). 1H NMR
the cyclomarins can be synthesized in enantiomerically pure (400 MHz, MeOD): δ = 1.76 (s, 3 H), 2.00 (s, 3 H), 3.97 (s, 2 H),
form in high yields. With these building blocks in hand, the 4.57 (s, 2 H), 4.93 (m, 1 H), 4.98 (m, 1 H) ppm. 13C NMR
cyclomarins A, C and D could be synthesised, using a finely (100 MHz, MeOD): δ = 19.5, 22.3, 42.1, 69.3, 113.5, 141.3,
adjusted protecting group strategy. All the cyclomarins show 171.1, 173.9 ppm.
activity towards Mycobacterium tuberculosis in the low μM rac-N-Acetyl-4-dehydroleucine (rac-7). In a Schlenk flask, di-
range, while cyclomarine A and C are the most potent ones. isopropyl amine (7.00 mL, 49.8 mmol) was dissolved in dry
THF (40 mL) and cooled down to −40 °C. To the resulting solu-
tion, n-BuLi (1.6 M in hexanes, 31.1 mL, 49.8 mmol) was
Experimental added dropwise. After stirring for 5 min at this temperature,
the cooling bath was removed and the mixture was allowed to
General experimental details warm up to room temperature.
All air- or moisture-sensitive reactions were carried out in In a second Schlenk flask, ZnCl2 (3.26 g, 23.9 mmol) was
dried glassware (>100 °C) under an atmosphere of nitrogen or heated with a heat gun in vacuo and dissolved in dry THF
argon. Dried solvents were distilled before use. The products (40 mL) after cooling. To this solution 6 (2.85 g, 16.6 mmol)
were purified by flash chromatography on silica gel columns was added, dissolved in dry THF (40 mL).
(Macherey-Nagel 60, 0.063–0.2 mm) and with a flash chromato- Both solutions were cooled down to −78 °C and the LDA-
graphy system [Reveleris (Grace), RediSep-columns 4 g, 12 g, solution was added slowly to the substrate solution via transfer
24 g and 40 g from Axel Semrau], using mixtures of ethyl cannula. The resulting mixture was allowed to warm up to
acetate and petroleum ether as eluents. Alternatively, a C-18 room temperature overnight. After dilution with diethyl ether
silica column was applied, using acetonitrile/water as eluent. (100 mL) 1 N KHSO4-solution was added (50 mL). The aqueous
Analytical TLC was performed on pre-coated silica gel plates layer was saturated with NaCl and extracted with diethyl ether
(Macherey-Nagel, Polygram® SIL G/UV254). Visualization was (3 × 100 mL). The combined organic layers were dried over
accomplished with UV-light, KMnO4 or a ceric ammonium Na2SO4 and the solvent was evaporated in vacuo. The crude
molybdate chamber. Melting points were determined with a residue was washed with a chloroform–pentane mixture (3 : 1,
melting point apparatus MelTEMP II by Laboratory devices and 50 mL) and with pentane (2 × 50 mL). The resulting acid
are uncorrected. 1H, and 13C spectra were recorded with a (2.51 g, 14.7 mmol, 89%) was obtained as a white crystalline
Bruker AV II 400 [400 MHz (1H), 100 MHz (13C)], or a Bruker AV solid. Melting point: 124–128 °C. 1H NMR (400 MHz, MeOD):
500 [500 MHz, (1H), 125 MHz (13C)] spectrometer in CDCl3 δ = 1.76 (s, 3 H), 1.96 (s, 3 H), 2.38 (dd, J = 14.3 Hz, 10.0 Hz,
unless otherwise specified. NMR spectra were evaluated using 1 H), 2.58 (dd, J = 14.3 Hz, 4.9 Hz, 1 H), 4.58 (dd, J = 10.0 Hz,
Mestrec. Chemical shifts are reported in ppm relative to 4.9 Hz, 1 H), 4.78 (s, 1 H), 4.83 (s, 1 H) ppm. 13C NMR
Si(CH3)4 and CHCl3 was used as the internal standard [δ(1H) = (100 MHz, MeOD): δ = 22.0, 22.3, 40.9, 52.1, 114.1, 142.4,
7.26 ppm, δ(13C) = 77.0 ppm]. High resolution mass spectra 173.3, 175.3 ppm. HRMS (CI): calculated: for C8H13NO3 [M]+
were recorded with a Finnigan MAT 95 spectrometer using the 171.0895, found 171.0900.
CI technique (M < 600 g mol−1) or with an Bruker maXis 4G (R)-N-Acetyl-4-dehydroleucine methyl ester [(R)-9], (S)-N-Boc-
UHR-TOF-spectrometer using the ESI technique (M > 4-dehydroleucine methyl ester [(S)-10]. Racemic N-acetyl de-
600 g mol−1). Optical rotations were measured with a Perkin- hydroleucine, rac-(7) (2.41 g, 14.6 mmol) was suspended in
Elmer polarimeter (model 341) in a thermostated (20 °C ± water (100 mL) and the pH was set to 6.8–7.0 by the means of
1 °C) cuvette. The radiation source used was a sodium vapor an automated titration apparatus filled with 0.1 M NaOH. To
lamp (λ = 589 nm). The concentrations are given in g per this mixture Acylase I (73 mg, isolated aminoacylase EC
100 ml. HPLC/MS analysis was performed with a Shimadzu 3.5.1.14. from porcine kidney) was added. The mixture was
system (LC: 10A-series with Autosampler, MS: LCMS-2020). stirred for 48 h at room temperature while the pH was main-
Elemental analyses were performed at the Saarland University. tained between 6.5 and 7.0. To this mixture NaHCO3 (2.10 g,
Preparation and analytical data of cyclomarin A and its syn- 25.0 mmol) and a solution of di-tert-butyl dicarbonate (4.37 g,
thetic intermediates war reported previously.29 20.0 mmol) in dioxane (50 mL) was added. The mixture was
N-Acetyl-glycine-(2-methallyl) ester (6). To a suspension of stirred overnight and acidified carefully with 1 N aq. KHSO4
N-acetyl glycine (10.5 g, 89.8 mmol) and 2-methyl-allyl alcohol (50 mL), before it was extracted with ethyl acetate (3 × 100 mL).
6044 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
The combined organic layers were dried over Na2SO4 and the (3S,5S)-3-Boc-amino-5-methyltetrahydro-2H-pyran-2-one (13).
solvent was removed in vacuo. To a solution of the alcohol 12 (94.0 mg, 360 µmol, dr 3 : 1) in
The residue was dissolved in dry DMF (20 mL) and was MeOH (3 mL) aq. NaOH (1 M, 380 mL, 380 µmol) was added at
cooled to 0 °C. To this solution K2CO3 (2.52 g, 18.3 mmol) and 0 °C. The mixture was allowed to warm to room temperature
methyl iodide (2.74 mL, 60.2 mmol) were added. The mixture overnight and the solvent was evaporated in vacuo. 1 N KHSO4
was stirred overnight at room temperature and diluted with (3 mL) and ethyl acetate (10 mL) were added to the residue.
ethyl acetate (100 mL), after TLC showed complete consump- The layers were separated and the organic layer was washed
tion of the starting material. The mixture was washed succes- with water. The solvent was removed in vacuo after drying over
sively with 1 N aq. KHSO4, sat. aq. NaHCO3, 5% aq. NaS2O3, Na2SO4. The residue was taken up in toluene (3 mL) and
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
water and brine. After drying (Na2SO4), the solvent was p-TsOH (6.0 mg, 36 µmol) was added. The mixture was heated
removed in vacuo and column chromatography of the crude to reflux until TLC showed complete conversion. The mixture
residue (silica, 1. petroleum ether/ethyl acetate 8 : 2; 2. ethyl was diluted with ethyl acetate (10 mL), and washed succes-
acetate) gave rise to (R)-9 (1.21 g, 6.28 mmol, 45%, 97% ee) as sively with 1 N KHSO4, sat. NaHCO3 and brine. The organic
a colourless resin and (S)-10 (1.53 g, 6.28 mmol, 43%, 98% ee) layer was dried over Na2SO4 and the solvent was removed
as a colourless oil. in vacuo. Column chromatography (silica, petroleum ether/
D = −22.6 (c = 1.0,
(R)-9: Rf [(R)-9]. 0.37 (ethyl acetate). [α]20 ethyl acetate 1 : 1) of the residue yielded pure major diastereo-
CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.73 (s, 3 H), 2.00 (s, mer (2S,4S)-13 (17.0 mg, 74 µmol, 21%) together with a mixed
3 H), 2.38 (dd, J = 13.9 Hz, 8.2 Hz, 1 H), 2.54 (dd, J = 13.9 Hz, fraction [15.0 mg, 66 µmol, 18%, ratio (2S,4S):(2S,4R) 3 : 2] as
5.5 Hz, 1 H), 3.73 (s, 3 H), 4.40 (ddd, J = 8.2 Hz, 5.5 Hz, 5.5 Hz, colourless oils. Rf [(2S,4S)-13]: 0.38; Rf [(2S,4R)-13]: 0.37
1 H), 4.74 (m, 1 H), 4.85 (m, 1 H), 5.90 (d, J = 5.5 Hz, 1 H) ppm. ( petroleum ether/ethyl acetate 1 : 1). [(2S,4S)-13]: 1H NMR
13
C NMR (100 MHz, CDCl3): δ = 21.7, 22.8, 40.4, 50.5, 52.2, (400 MHz, CDCl3): δ = 1.04 (d, J = 6.9 Hz, 3 H), 1.33 (m, 1 H),
114.3, 140.4, 169.8, 172.8 ppm. HRMS (CI): calculated for 1.44 (s, 9 H), 2.27 (m, 1 H), 2.60 (m, 1 H), 3.98 (dd, J = 11.4 Hz,
C9H16NO3 [M + H]+ 186.1125, found 186.1129. 6.9 Hz, 1 H), 4.25 (m, 1 H), 4.37 (ddd, J = 11.4 Hz, 4.8 Hz,
(S)-10: Rf [(S)-10]. 0.65 (ethyl acetate). [α]20
D = +9.6 (c = 1.0, 1.1 Hz, 1 H), 5.32 (bs, 1 H) ppm. 13C NMR (100 MHz, CDCl3):
CHCl3). Mixture of rotamers. Major rotamer: 1H NMR δ = 18.3, 27.7, 28.3, 35.1, 49.9, 74.1, 80.2, 155.4, 171.8 ppm.
(400 MHz, CDCl3): δ = 1.43 (s, 9 H), 1.74 (s, 3 H), 2.36 (dd, J = HRMS (CI): calculated for C11H20NO4 [M + H]+ 230.1387, found
13.8 Hz, 8.4 Hz, 1 H), 2.51 (dd, J = 13.8 Hz, 5.5 Hz, 1 H), 3.73 230.1393.
(s, 3 H), 4.40 (m, 1 H), 4.75 (s, 1 H), 4.85 (s, 1 H), 4.93 (d, J = (2S,4R)-N-Cbz-4-methyl-5-[(tert-butyldimethylsilyl)oxy]-leucine
6.8 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = δ = 21.8, (19). To a solution of the methyl ester 18 29 (110 mg, 270 µmol)
28.2, 40.7, 51.8, 52.1, 79.8, 114.4, 140.5, 155.2, 173.0 ppm. in MeOH (3 mL) 1 M NaOH (300 µL, 300 µmol) was added at
Minor rotamer (selected signals) 1H NMR (400 MHz, CDCl3): 0 °C. The mixture was allowed to warm to room temperature
δ = 4.21 (bs, 1 H), 4.62 (bs, 1 H) ppm. HRMS (CI): calculated over night and the solvent was removed in vacuo. The residue
C12H22NO3 [M + H]+ 244.1543, found 244.1547. was dissolved in water and was washed with dichloromethane
(2S,4R/S)-N-Boc-5-hydroxyleucine methyl ester (12). To a (5 mL). The aqueous layer was acidified using 1 N KHSO4 and
solution of (S)-10 (500 mg, 2.06 mmol) in THF (10 mL) a extracted with dichloromethane (3 × 10 mL). The resulting
9-BBN-solution (0.5 M in THF, 412 µL, 206 µmol) was added organic layers were combined, dried over NaSO4 and concen-
dropwise. After TLC showed complete conversion, 30% H2O2 trated in vacuo. The acid 19 (106 mg, 270 µmol) was obtained
(2 mL) and phosphate buffer ( pH 7, 2 mL) were added. The as a colourless oil and was used without further purification.
mixture was stirred overnight, diluted with sat. aq. Na2S2O3 Rf (19): 0.27 ( petroleum ether/ethyl acetate 7 : 3). [α]20
D = +2.5
solution and extracted with ethyl acetate (3 × 20 mL). The com- (c = 1.0, CHCl3). Mixture of rotamers. Major rotamer: 1H NMR
bined organic layers were dried (Na2SO4) and the solvent was (400 MHz, CDCl3): δ = 0.04 (s, 3 H), 0.05 (s, 3 H), 0.88 (s, 9 H),
evaporated in vacuo. Column chromatography (silica, 0.93 (d, J = 6.7 Hz, 3 H), 1.57 (m, 1 H), 1.81 (m, 1 H), 1.93 (m,
petroleum ether, ethyl acetate 1 : 1) gave rise to alcohol 12 1 H), 3.40 (dd, J = 9.9 Hz, 6.5 Hz, 1 H), 3.58 (dd, J = 9.9 Hz,
(283 mg, 1.08 mmol, 53%) as a colourless resin and a mixture 4.8 Hz, 1 H), 4.39 (m, 1 H), 5.09 (d, J = 12.3 Hz, 1 H), 5.13 (d,
of diastereomers [dr = 3 : 1 (NMR)]. Rf [(2S,4S)-12]: 0.28; J = 12.3 Hz, 1 H), 5.82 (d, J = 7.6 Hz, 1 H), 7.27–7.38 (m, 5 H)
Rf [(2S,4R)-12]: 0.29 ( petroleum ether/ethyl acetate 1 : 1). [α]20
D = ppm. 13C NMR (100 MHz, CDCl3): δ = −5.5, −5.5, 17.5, 18.3,
+15.7 (c = 1.0, CHCl3). [(2S,4S)-12]: 1H NMR (400 MHz, CDCl3): 25.9, 32.4, 35.9, 52.3, 67.0, 67.4, 128.0, 128.1, 128.5, 136.2,
δ = 0.97 (d, J = 6.7 Hz, 3 H), 1.43 (s, 9 H), 1.59 (m, 1 H), 1.75 156.2, 177.1 ppm. Minor rotamer (selected signals): 1H NMR
(m, 2 H), 1.97 (bs, 1 H), 3.43 (dd, J = 10.6 Hz, 6.2 Hz, 1 H), 3.57 (400 MHz, CDCl3): δ = 0.91 (d, J = 5.0 Hz, 3 H), 3.64 (m, 1 H),
(dd, J = 10.6 Hz, 4.9 Hz, 1 H), 3.73 (s, 3 H), 4.33 (m, 1 H), 5.13 3.74 (m, 1 H), 4.33 (bs, 1 H), 5.82 (bs, 1 H) ppm. HRMS (CI):
(d, J = 7.0 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 17.1, calculated for C20H34NO5Si [M + H]+ 396.2201, found
20.6, 28.3, 36.3, 49.9, 51.8, 71.9, 79.9, 155.4, 173.0 ppm. 396.2199.
[(2S,4S)-12] (selected signals): 1H NMR (400 MHz, CDCl3): δ = (4R,5R)-4-[(tert-Butyldimethylsilyloxy)methyl]-5-phenyloxazoli-
1.89 (m, 2 H), 4.45 (m, 1 H), 5.25 (d, J = 6.0 Hz, 1 H) ppm. din-2-one (23). To a solution of alcohol 22 29 (80.0 mg,
HRMS (CI): calculated for C12H25NO5 [M + H]+ 262.1649, found 210 µmol) in dry THF (2 mL) NaH (60% dispersion in mineral
262.1637. oil, 16.5 mg, 410 µmol) was added at 0 °C. The mixture was
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6045
View Article Online
allowed to warm to room temperature overnight and was HRMS (CI): calculated for C27H44N2O6Si [M]+ 520.2963, found
quenched with 1 N KHSO4. The mixture was extracted with 520.2991.
diethyl ether (3 × 10 mL) and the combined organic layers (2R,3R)-N,N′-(Bis-Boc)-1-O-(tert-butyldimethylsilyl)-3-acetoxy-
were washed with sat. aq. NaHCO3 and brine. The solvent was tryptophanol (28). To a solution of alcohol 27 (305 mg,
removed in vacuo after drying over Na2SO4. Column chromato- 587 µmol) in dichloromethane (6 mL) triethylamine (90.0 µL,
graphy (silica, petroleum ether/ethyl acetate 1 : 1) gave rise to 645 µmol), acetic anhydride (61.0 µL, 645 mmol) and DMAP
the oxazolidione 23 (44.0 mg, 143 µmol, 68%) as a colourless (7.3 mg, 0.06 mmol) were added at 0 °C. The mixture was
resin. Rf (23): 0.29 (petroleum ether/ethyl acetate 8 : 2). [α]20D = allowed to warm to 0 °C overnight, diluted with dichloro-
+27.3 (c = 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 0.09 (s, methane (20 mL) and washed with 1 N KHSO4, sat. NaHCO3
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
3 H), 0.1 (s, 3 H), 0.91 (s, 9 H), 3.74 (m, 2 H), 3.79 (m, 1 H), 5.34 and brine. The solvent was removed in vacuo after drying
(d, J = 4.9 Hz, 1 H), 6.53 (bs, 1 H), 7.34–7.41 (m, 5 H) ppm. 13C (Na2SO4) and the residue was purified by column chromato-
NMR (100 MHz, CDCl3): δ = −5.5, 18.1, 25.7, 61.1, 64.4, 80.0, graphy (silica, petroleum ether/ethyl acetate 95 : 5). Acetate 28
125.5, 128.6, 128.8, 139.0, 159.4 ppm. HRMS (CI): calculated for (276 mg, 491 µmol, 84%) was obtained as a yellow resin.
C16H26NO3Si [M + H]+ 308.1676, found 308.1674. Rf (28): 0.62 ( petroleum ether/ethyl acetate 9 : 1). [α]20D = −61.4
(2R,3R)-N,N′-(Bis-Boc)-1-O-(tert-butyldimethylsilyl)-3-hydroxy- (c = 1.0, CHCl3). Mixture of rotamers. Major rotamer: 1H NMR
tryptophanol (27). To a solution of D-N-Boc-O-(tert-butyldi- (400 MHz, CDCl3): δ = −0.02 (s, 6 H), 0.01 (s, 6 H), 0.91 (s,
methylsilyl)-serine methyl ester29 (334 mg, 1.00 mmol) in dry 9 H), 1.46 (s, 9 H), 1.65 (s, 9 H), 2.06 (s, 3 H), 3.46 (dd, J = 10.2
toluene (10 mL) DIBAL-H (1 M in hexanes, 1.4 mL, 1.4 mmol) Hz, 2.1 Hz, 1 H), 3.58 (dd, J = 10.2 Hz, 4.1 Hz, 1 H), 4.33 (m,
was added at −78 °C over a period of 30 min. After TLC 1 H), 5.03 (d, J = 9.8 Hz, 1 H), 6.23 (d, J = 8.8 Hz, 1 H), 7.24
showed complete consumption of the starting material, di- (ddd, J = 8.0 Hz, 8.0 Hz, 1.0 Hz, 1 H), 7.33 (m, 1 H), 7.61 (s,
chloromethane (10 mL) was added, followed by 1 M HCl. The 1 H), 7.81 (d, J = 8.0 Hz, 1 H), 8.17 (d, J = 8.0 Hz, 1 H) ppm.
mixture was allowed to warm to 0 °C and was stirred at that 13
C NMR (100 MHz, CDCl3): δ = −5.6, −5.6, 18.2, 21.1, 25.9,
temperature until the solution became clear. After extraction 28.2, 28.4, 54.4, 62.5, 69.1, 79.5, 83.9, 115.3, 117.1, 120.3,
of the aq. layer with dichloromethane (3 × 10 mL), the com- 122.9, 124.8, 128.3, 135.7, 149.4, 155.7, 170.5 ppm. Minor
bined organic layers were washed with sat NaHCO3 dried over rotamer: 1H NMR (selected signals, 400 MHz, CDCl3): δ = 1.36
Na2SO4 and the solvent was removed in vacuo. The crude alde- (s, 9 H), 4.12 (m, 1 H), 4.72 (m, 1 H) ppm. HRMS (CI): calcu-
hyde 21 was immediately used in the next step. lated for C29H64N2O7Si [M]+ 562.3069, found 562.3073.
The iodinated Boc-indole 26 53 (1.03 g, 3.00 mmol) was dis- (2R,3R)-N,N′-(Bis-Boc)-1-O-(tert-butyldimethylsilyl)-3-(methoxy-
solved in dry THF (10 mL) and cooled down to −10 °C. To this methylenoxy)-tryptophanol (29). To a solution of the secondary
solution, diisopropyl magnesium chloride (2 M in diethyl alcohol 27 29 (1.12 g, 2.15 mmol) in dry dichloromethane
ether, 1.50 mL, 3.00 mmol) was added dropwise. The mixture (10 mL) DIPEA (2.07 mL, 11.8 mmol) and MOMCl (820 µL,
was stirred for 45 min at that temperature and cooled down to 10.8 mmol) were added at 0 °C. The mixture was warmed to
−20 °C. room temperature overnight and was diluted with ethyl acetate
The crude aldehyde 21 was dissolved in dry THF (5 mL) and (50 mL) after TLC showed full conversion. The resulting
added to the solution of the indole at −20 °C. After stirring for mixture was washed with 1 N KHSO4, sat NaHCO3 and brine.
2 h at −20 °C, the mixture was allowed to warm up to 0 °C and The solvent was evaporated after drying over Na2SO4. Column
was quenched with 1 N aq. KHSO4. After extraction with ethyl chromatography (silica, petroleum ether/ethyl acetate 9 : 1) of
acetate (3 × 20 mL), the combined organic layers were washed the crude residue gave rise to the protected alcohol 29
with sat. NaHCO3 and brine. After drying (Na2SO4), the solvent (971 mg, 1.72 mmol, 80%) as a colourless resin. Rf (29): 0.43
was removed in vacuo and the residue was subjected to column ( petroleum ether/ethyl acetate 8 : 2). [α]20 D = −73.8 (c = 1.0,
chromatography (silica, petroleum ether/ethyl acetate 9 : 1). CHCl3). 1H NMR (400 MHz, CDCl3): δ = 0.03 (s, 6 H), 0.04 (s,
The pure major diastereomer 27 (339 mg, 651 µmol, 65%) was 6 H), 0.92 (s, 9 H), 1.40 (s, 9 H), 1.65 (s, 9 H), 3.39 (s, 3 H), 3.82
obtained as a colourless resin. Rf (27): 0.31 ( petroleum ether/ (dd, J = 9.8 Hz, 3.2 Hz, 1 H), 3.89 (dd, J = 9.8 Hz, 6.2 Hz, 1 H),
ethyl acetate 8 : 2). (2S,3R)-27: [α]20 D = −19.1 (c = 1.0, 4.07 (m, 1 H), 4.56 (d, J = 6.7 Hz, 1 H), 4.63 (d, J = 6.7 Hz, 1 H),
CHCl3).1H NMR (400 MHz, CDCl3): δ = 0.09 (s, 6 H), 0.94 (s, 5.05 (d, J = 9.3 Hz, 1 H), 5.11 (d, J = 5.6 Hz, 1 H), 7.21 (dd, J =
9 H), 1.41 (s, 9 H), 1.65 (s, 9 H), 3.65 (s, 1 H), 3.82 (m, 1 H), 7.4 Hz, 7.4 Hz, 1 H), 7.30 (dd, J = 7.4 Hz, 7.4 Hz, 1 H), 7.55 (s,
3.89 (dd, J = 10.1 Hz, 3.9 Hz, 1 H), 4.02 (m, 1 H), 5.24–5.30 (m, 1 H), 7.72 (d, J = 7.4 Hz, 1 H), 8.14 (bs, 1 H) ppm. 13C NMR
2 H), 7.22 (dd, J = 8.0 Hz, 8.0 Hz, 1 H), 7.31 (dd, J = 8.0 Hz, 8.0 (100 MHz, CDCl3): δ = −5.5, −5.4, 18.2, 25.8, 28.1, 28.3, 55.6,
Hz, 1 H), 7.49 (s, 1 H), 7.64 (d, J = 8.0 Hz, 1 H), 8.16 (d, J = 8.0 55.7, 62.3, 70.4, 79.1, 83.6, 94.3, 115.2, 118.4, 120.3, 122.6,
Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = −5.5, 18.2, 25.9, 124.5, 128.9, 135.8, 149.5, 155.7 ppm. HRMS (CI): calculated
28.2, 28.4, 55.0, 64.9, 69.3, 79.7, 83.6, 115.3, 119.6, 121.9, for C29H48N2O7Si [M]+ 564.3225, found 564.3225.
122.6, 123.3, 124.5, 128.6, 135.8, 149.5, 155.8 ppm. (2S,3S)-27: (2R,3R)-N,N′-(Bis-Boc)-3-(methoxymethylenoxy)-tryptophanol
1
H NMR (selected signals, 400 MHz, CDCl3): δ = (s, 3 H), 0.07 (30). To a solution of the protected tryptophanol 29 (864 mg,
(s, 3 H), 0.92 (s, 9 H), 1.47 (s, 9 H), 4.07 (m, 1 H), 5.45 (d, J = 1.50 mmol) in THF (10 mL) TBAF trihydrate (473 mg,
9.1 Hz, 1 H) ppm. 13C NMR (selected signals, 100 MHz, 1.50 mmol) was added at 0 °C. The mixture was warmed to
CDCl3): 53.6, 63.6, 71.3, 124.6, 128.1, 136.0, 149.6, 156.3 ppm. room temperature and the solvent was removed in vacuo after
6046 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
TLC showed complete conversion. Column chromatography Zinc-reagent. In a Schlenk flask, ZnCl2 (1.80 g, 13.2 mmol)
(silica, petroleum ether/ethyl acetate 1 : 1) of the residue gave and LiCl (736 mg, 18.0 mmol) were dried with a heat gun
rise to the primary alcohol 30 (643 mg, 95%) as a colourless in vacuo and dissolved in dry THF (15 mL) after cooling down
resin. Rf (30): 0.31 ( petroleum ether/ethyl acetate 1 : 1). [α]20
D = to room temperature. Then, Mg-turnings (729 mg, 30.0 mmol)
−85.3 (c = 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.35 (s, and a solution of the iodoindole 34 (3.73 g, 12.0 mmol) in dry
9 H), 1.66 (s, 9 H), 2.77 (bs, 1 H), 3.41 (s, 3 H), 3.82 (dd, J = THF (15 mL) were added subsequently. To the resulting
11.1 Hz, 5.2 Hz, 1 H), 3.89 (m, 1 H), 4.04 (m, 1 H), 4.56 (d, J = mixture dibromoethane (70 µL) was added, what caused an
6.7 Hz, 1 H), 4.63 (d, J = 6.7 Hz, 1 H), 5.12 (d, J = 5.1 Hz, 1 H), exothermic reaction. After heat development had ceased, stir-
5.20 (bs, 1 H), 7.22 (m, 1 H), 7.31 (m, 1 H), 7.57 (s, 1 H), 7.67 ring was continued for 2 h at room temperature and the excess
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
(d, J = 7.7 Hz, 1 H), 8.13 (d, J = 7.8 Hz, 1 H) ppm. 13C NMR Mg-turnings were filtrated under inert gas atmosphere.
(100 MHz, CDCl3): δ = 28.1, 55.9, 56.2, 63.1, 71.3, 79.6, 83.9, Addition reaction. The solution of the zinc-reagent was
94.3, 115.3, 117.8, 120.0, 122.7, 124.6, 124.7, 128.8, 135.7, cooled to −78 °C and a solution of the crude aldehyde in dry
149.5, 156.1 ppm. HRMS (CI): calculated for C23H34N2O7 [M]+ THF (15 mL) was added dropwise. The reaction mixture was
450.2361, found 450.2370. allowed to warm up to room temperature, diluted with diethyl
(2S,3R)-N,N′-(Bis-Boc)-3-(methoxymethylenoxy)-tryptophan ether (40 mL) and quenched with sat. aq. NH4Cl. The aqueous
methyl ester (31). To a solution of the primary alcohol 30 layer was extracted with diethyl ether (3 × 50 mL) and the com-
(612 mg, 1.36 mmol) in acetonitrile (1.5 mL) and phosphate bined organic layers were washed subsequently with sat. aq.
buffer ( pH 6.4, 1.5 mL) TEMPO (42.0 mg, 272 µmol) and PhI- NaHCO3, 5% aq. Na2S2O3 and brine. After drying over Na2SO4,
(OAc)2 (BAIB, 44.0 mg, 136 µmol) were added at room tempera- the solvent was removed in vacuo and column chromatography
ture. The resulting mixture was cooled to 0 °C before NaClO2 (silica, petroleum ether/ethyl acetate 9 : 1 to 8 : 2) gave rise to
(80%, 507 mg, 4.49 mmol) was added. After stirring for 15 min the secondary alcohol 36 (1.41 g, 2.98 mmol, 75%, >90% ds).
at this temperature, 1 N KHSO4 was added and the layers were The product proved to be extremely sensitive and had to be
separated. The aqueous layer was extracted with dichloro- used immediately in the next step or stored under inert atmo-
methane (3 × 5 mL) and the combined organic layers were sphere below −20 °C. Rf (36): 0.20 ( petroleum ether/ethyl
D = −34.7 (c = 1.0, CHCl3). (2R,3R)-36: H NMR
acetate 8 : 2). [α]20 1
washed with 5% Na2S2O3. After drying over Na2SO4, the
solvent was evaporated and the residue was taken up in diethyl (400 MHz, CDCl3): δ = 0.08 (s, 6 H), 0.94 (s, 9 H), 1.74 (s, 6 H),
ether (10 mL), before diazomethane was added. The solvent 3.28 (bs, 1 H), 3.80 (m, 1 H), 3.87 (dd, J = 10.1 Hz, 4.1 Hz, 1 H),
was removed in vacuo and column chromatography (silica, pet- 4.14 (m, 1 H, 14 H), 4–58 (m, 1 H), 5.15 (d, J = 17.5 Hz, 1 H),
roleum ether/ethyl acetate 85 : 15) gave rise to ester 31 5.21 (d, J = 10.7 Hz, 1 H), 5.18–5.32 (m, 2 H), 5.36 (m, 1 H),
(540 mg, 1.13 mmol, 83%) as a colourless resin. Rf (31): 0.43 5.52 (d, J = 8.5 Hz, 1 H), 5.91 (m, 1 H), 6.13 (dd, J = 17.5 Hz,
( petroleum ether/ethyl acetate 8 : 2). [α]20 D = −59.8 (c = 1.0, 10.7 Hz, 1 H), 7.08 (ddd, J = 7.1 Hz, 7.1 Hz, 1.2 Hz, 1 H), 7.12
CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.28 (s, 9 H), 1.66 (s, (ddd, J = 6.9 Hz, 6.9 Hz, 1.4 Hz, 1 H), 7.33 (s, 1 H), 7.50 (d, J =
9 H), 3.32 (s, 3 H), 3.80 (s, 3 H), 4.53 (d, J = 6.9 Hz, 1 H), 4.62 7.6 Hz, 1 H), 7.71 (d, J = 7.1 Hz, 1 H) ppm. 13C NMR (100 MHz,
(d, J = 6.9 Hz, 1 H), 4.66 (dd, J = 9.7 Hz, 2.5 Hz, 1 H), 5.46–5.50 CDCl3): δ = −5.6, 18.2, 25.8, 27.9, 28.0, 55.8, 59.0, 64.7, 65.5,
(m, 2 H), 7.23 (m, 1 H), 7.30 (m, 1 H), 7.60 (s, 1 H), 7.65 (d, J = 69.1, 113.5, 113.9, 117.5, 119.1, 119.3, 120.9, 123.1, 127.6,
7.8 Hz, 1 H), 8.11 (d, J = 7.7 Hz, 1 H) ppm. 13C NMR (100 MHz, 132.9, 135.8, 156.6 ppm. (2R,3S)-36: (selected signals,
CDCl3): δ = 28.1, 28.1, 52.4, 55.7, 58.3, 71.5, 79.7, 83.9, 94.0, 400 MHz, CDCl3): δ = 0.07 (s, 6 H), 0.93 (s, 9 H), 1.75 (s, 6 H),
115.3, 116.9, 119.7, 122.8, 124.5, 124.6, 128.8, 135.5, 149.4, 3.14 (bs, 1 H), 3.66 (m, 2 H), 4.06 (m, 1 H), 4.63 (m, 2 H), 5.63
155.3, 170.9 ppm. HRMS (CI): calculated for C24H35N2O8 (d, J = 8.7 Hz, 1 H), 7.21 (m, 1 H), 7.38 (s, 1 H), 7.67 (d, J = 8.2
[M + H]+ 479.2388, found 479.2389. Hz, 1 H) ppm. 13C NMR (selected signals, 100 MHz, CDCl3):
(2R,3R)-N-Alloc-N′-(tert-prenyl)-1-O-(tert-butyldimethylsilyl)-3- δ = −5.7, 25.7, 28.0, 59.1, 63.4, 118.0, 119.2, 119.7, 127.2,
hydroxytryptophanol (36) 132.5 ppm. HRMS (CI): calculated for C26H40N2O4Si [M]+
DIBAL-H-reduction. To a solution of (D)-N-Alloc-O-(tert- 472.2752, found 472.2753.
butyldimethylsilyl)-serine methyl ester 35 29 (1.27 g, (2R,3R)-N-Alloc-N′-(tert-prenyl)-1-O-(tert-butyldimethylsilyl)-
4.00 mmol) in dry toluene (40 mL) DIBAL-H (1 M in hexanes, 3-[(tert-butyldimethylsilyl)oxy]-tryptophanol (37). A solution of
4.00 mL, 4.00 mmol) was added at −78 °C over a period of the secondary alcohol 36 (340 mg, 719 µmol) in dry dichloro-
30 min. The mixture was stirred for 2–3 h at this temperature methane (7 mL) was cooled down to −35 °C and a solution of
and after TLC showed full conversion, dichloromethane TBDMSOTf (180 µL, 791 µmol) and 2,6-lutidine (170 µL,
(20 mL) followed by 1 M HCl (10 mL) were added. The result- 1.45 mmol) in dry dichloromethane (2 mL) was added drop-
ing mixture was allowed to warm to 0 °C and was stirred at this wise. After addition was complete, the mixture was stirred for
temperature until both layers became clear. The layers were 5 min at this temperature and quenched with sat. aq. NaHCO3.
separated and the aqueous layer was extracted with dichloro- After warming up to room temperature, the mixture was
methane (3 × 30 mL). The combined organic layers were diluted with dichloromethane (20 mL) and the organic layer
washed with sat. NaHCO3 and dried over NaSO4. The solvent was washed with subsequently with 1 N aq. KHSO4 and water.
was removed in vacuo and the crude aldehyde was used After drying over Na2SO4 the solvent was removed in vacuo.
immediately without further purification. Column chromatography (silica, petroleum ether/ethyl acetate
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6047
View Article Online
8 : 2) gave rise to the diastereomerically pure, protected alcohol resulting very sensitive crude aldehyde was immediately used
37 (369 mg, 629 µmol, 87%) as a colourless resin. Rf (37): 0.34 in the next step.
( petroleum ether/ethyl acetate 9 : 1). [α]20 D = −54.3 (c = 1.0, K2CO3 (262 mg, 1.90 mmol) was added to a solution of the
CHCl3). Mixture of rotamers. Major rotamer: 1H NMR aldehyde in methanol (8 mL) at 0 °C. After addition of
(400 MHz, CDCl3): δ = −0.18 (s, 3 H), 0.06 (s, 3 H), 0.10 (s, 2-methyl-2-butene (1 mL), N-iodosuccinimide (428 mg,
6 H), 0.89 (s, 9 H), 0.97 (s, 9 H), 1.72 (s, 3 H), 1.73 (s, 3 H), 3.63 1.90 mmol) was added under light exclusion. After TLC
(d, J = 6.2 Hz, 2 H), 3.92 (m, 1 H), 4.52 (d, J = 5.4 Hz, 2 H), showed full conversion, the reaction was quenched with 5%
4.98–5.35 (m, 5 H), 5.38 (d, J = 3.7 Hz, 1 H), 5.91 (m, 1 H), 6.13 Na2S2O3 and extracted with dichloromethane (3 × 15 mL). The
(dd, J = 17.4 Hz, 10.7 Hz, 1 H), 7.02–7.14 (m, 2 H), 7.21 (s, 1 H), combined organic layers were dried over Na2SO4 and the
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
7.47 (d, J = 8.1 Hz, 1 H), 7.65 (d, J = 7.4 Hz, 1 H) ppm. 13C NMR solvent was removed in vacuo. Column chromatography (silica,
(100 MHz, CDCl3): δ = −5.4, −5.3, −4.6, 18.2, 18.2, 25.8, 25.9, petroleum ether/ethyl acetate 9 : 1) gave rise to the methyl ester
28.0, 57.9, 58.9, 61.8, 65.3, 66.6, 113.4, 113.7, 115.3, 117.5, 39 (286 mg, 572 µmol, 90%) as a yellow oil. Rf (39): 0.34 ( pet-
118.8, 119.5, 120.6, 123.3, 127.6, 133.2, 135.6, 144.1, D = −63.8 (c = 1.0, CHCl3).
roleum ether/ethyl acetate 8 : 2). [α]20
156.0 ppm. Minor rotamer: 1H NMR (selected signals, Mixture of rotamers. Major rotamer: 1H NMR (400 MHz,
400 MHz, CDCl3): δ = −0.14 (s, 3 H), 0.05 (s, 3 H), 0.09 (s, 6 H), CDCl3): δ = −0.15 (s, 3 H), 0.00 (s, 3 H), 0.88 (s, 9 H), 1.72 (s,
1.76 (s, 3 H), 1.81 (s, 3 H), 3.85 (m, 1 H), 4.39 (m, 2 H), 5.42 3 H), 1.73 (s, 3 H), 3.78 (s, 3 H), 4.45 (m, 2 H), 4.56 (dd, J =
(m, 1 H), 5.65 (m, 1 H), 6.13 (dd, J = 17.4 Hz, 10.7 Hz, 1 H), 9.4 Hz, 2.3 Hz, 1 H), 5.08 (d, J = 17.4 Hz, 1 H), 5.13–5.27 (m,
7.24 (s, 1 H), 7.59 (d, J = 6.8 Hz, 1 H) ppm. 13C NMR (selected 3 H), 5.61 (d, J = 9.4 Hz, 1 H), 5.66 (d, J = 2.3 Hz, 1 H), 5.85 (m,
signals, 100 MHz, CDCl3): δ = −5.3, 28.1, 58.2, 62.2, 117.0, 1 H), 6.12 (dd, J = 17.4 Hz, 10.7 Hz), 7.06–7.14 (m, 2 H), 7.24 (s,
118.9, 120.6, 123.7, 127.3 ppm. HRMS (CI): calculated for 1 H), 7.48 (m, 1 H), 7.63 (m, 1 H) ppm. 13C NMR (100 MHz,
C28H45N2O4Si2 [M − C4H9]+ 529.2912, found 529.2922. CDCl3): δ = −5.6, −4.7, 18.1, 25.6, 28.0, 28.1, 52.2, 59.0, 60.3,
(2R,3R)-N-Alloc-N′-(tert-prenyl)-3-[(tert-butyldimethylsilyl)oxy]- 65.6, 69.6, 113.5, 113.8, 113.9, 117.6, 118.8, 119.1, 120.8, 123.,
tryptophanol (38). To a solution of the fully protected diol 37 127.1, 132.8, 135.5, 143.9, 156.0, 171.2 ppm. Minor rotamer:
(1.05 g, 1.84 mmol) in methanol (20 mL) NH4F (683 mg, 1
H NMR (selected signals, 400 MHz, CDCl3): δ = −0.12 (s, 3 H),
18.5 mmol) was added at 0 °C. The mixture was allowed to 0.06 (s, 3 H), 0.90 (s, 9 H), 1.76 (s, 3 H), 1.80 (s, 3 H), 3.81 (s,
warm up to room temperature and was stirred for 48 h in total. 3 H), 4.02 (dd, J = 13.4 Hz, 5.4 Hz, 1 H), 4.30 (dd, J = 13.4 Hz,
Ethyl acetate was added (60 mL) and the resulting mixture was 5.1 Hz, 1 H), 4.53 (m, 1 H), 4.84 (d, J = 17.2 Hz, 1 H), 4.90 (d,
washed subsequently with water, sat. NaHCO3 and brine. After J = 10.3 Hz, 1 H), 5.36 (m, 1 H), 5.41 (d, J = 9.9 Hz, 1 H) ppm.
drying over Na2SO4, the solvent was removed in vacuo and 13
C NMR (selected signals, 100 MHz, CDCl3): δ = −5.4, −4.7,
column chromatography (silica, petroleum ether/ethyl acetate 25.7, 27.8, 51.8, 60.4, 65.4, 69.7, 113.6, 116.9, 118.3, 124.1,
8 : 2) of the residue yielded the primary alcohol 37 (722 mg, 126.8, 132.1, 155.6, 171.1 ppm. HRMS (CI): calculated for
1.53 mmol, 83%) as a colourless resin. Rf (37): 0.28 ( petroleum C21H25N2O4 [M − TBDMSO]+ 369.1809, found 369.1813.
D = −34.5 (c = 1.0, CHCl3). H NMR
ether/ethyl acetate 7 : 3). [α]20 N-Cbz-(2S,4R)-[5-(tert-butyldimethylsilyl)oxy-leucyl]-(S)-alanyl-
1
(400 MHz, CDCl3): δ = −0.12 (s, 3 H), 0.06 (s, 3 H), 0.89 (s, (2S,3R)-(3-methoxyphenylalanyl)-(S)-valyl-(S)-N-methylleucine
9 H), 1.72 (s, 3 H), 1.72 (s, 3 H), 3.75 (m, 2 H), 3.99 (m, 1 H), methyl ester (49b). To the tetrapeptide 48 29 (118 mg,
4.53 (m, 2 H), 5.10 (d, J = 17.4 Hz, 1 H), 5.21 (d, J = 10.7 Hz, 194 µmol) HCl (4 M in dioxane, 500 µL, 2.0 mmol) was added
1 H), 5.15–5.31 (m, 4 H), 5.88 (m, 1 H), 6.12 (dd, J = 17.4 Hz, at room temperature. After TLC showed full conversion, the
10.7 Hz, 1 H), 7.07 (m, 1 H), 7.11 (m, 1 H), 7.25 (s, 1 H), solvent was removed in vacuo. The obtained hydrochloride was
7.48 (d, J = 7.8 Hz, 1 H), 7.62 (d, J = 7.4 Hz, 1 H) ppm. 13C NMR dissolved in dry dichloromethane (3 mL), the acid 19 (70.0 mg,
(100 MHz, CDCl3): δ = −5.4, −5.7, 18.1, 25.8, 28.0, 58.1, 177 µmol) was added and the mixture was cooled down to
59.1, 63.2, 65.6, 68.6, 113.6, 113.9, 114.2, 117.6, 119.1, 119.3, 0 °C. To the resulting solution, EDC·HCl (37.1 mg, 194), NMM
120.9, 123.6, 127.5, 132.8, 135.6, 143.9, 156.7 ppm. HRMS (CI): (22 µL, 0.19 mmol) and HOBt (3.4 mg, 22 µmol) were added
calculated for C26H39N2O3Si [M − OH]+ 455.2724, found successively. The mixture was allowed to warm up to room
455.2730. temperature, diluted with ethyl acetate (20 mL) and washed
(2S,3R)-N-Alloc-N′-(tert-prenyl)-3-[(tert-butyldimethylsilyl)oxy]- with 1 N KHSO4, sat. NaHCO3 and brine. The solvent was
tryptophan methyl ester (39). The primary alcohol 38 (300 mg, removed in vacuo after drying over Na2SO4. Flash chromato-
643 µmol) was dissolved in a mixture of dry dichloromethane graphy (4 g C-18-silica, H2O/MeCN gradient) gave rise to the
(5 mL) and dry DMSO (4 mL). Triethylamine (450 µl, pentapeptide 49b (123 mg, 139 µmol, 79%) as a colourless
3.17 mmol) was added and the mixture was cooled to 0 °C. resin. Rf (49b): 0.34 ( petroleum ether/ethyl acetate 1 : 1). [α]20
D =
A solution of pyridine·SO3 (403 mg, 2.54 mmol) in dry DMSO −52.3 (c = 1.0, CHCl3). 1H NMR (500 MHz, CDCl3): δ = 0.04 (s,
(2.5 mL) was added over a period of 15 min. The mixture was 3 H), 0.05 (s, 3 H), 0.87 (s, 9 H), 0.89 (d, J = 6.8 Hz, 3 H), 0.91
allowed to warm up slowly to room temperature and after TLC (d, J = 6.4 Hz, 3 H), 0.94 (d, J = 6.7 Hz, 3 H), 0.95 (d, J = 6.6 Hz,
showed full conversion, ethyl acetate (30 mL) was added and 3 H), 1.00 (d, J = 6.8 Hz, 3 H), 1.23 (d, J = 7.0 Hz, 3 H), 1.49 (m,
the resulting mixture was washed subsequently with 1 N 1 H), 1.64–1.85 (m, 5 H), 2.14 (m, 1 H), 2.99 (s, 3 H), 3.32 (s,
KHSO4, sat. NaHCO3, 5% Na2S2O3 and brine. After drying over 3 H), 3.40 (dd, J = 10.1 Hz, 6.4 Hz, 1 H), 3.53 (dd, J = 10.1 Hz,
Na2SO4, the solvent was removed in vacuo at 0 °C and the 4.7 Hz, 1 H), 3.69 (s, 3 H), 4.33 (m, 1 H), 4.34 (m, 1 H), 4.69
6048 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
(dd, J = 7.7 Hz, 3.6 Hz, 1 H), 4.80–4.84 (m, 2 H), 5.11 (s, 1 H), 132.3, 135.9, 137.0, 143.7, 156.7, 168.5, 168.6, 168.6, 170.4,
5.35 (dd, J = 10.5 Hz, 5.3 Hz, 1 H), 5.95 (d, J = 6.7 Hz, 1 H), 6.67 170.6, 171.6, 171.6, 171.6, 171.9, 172.1, 172.1 ppm. Minor
(d, J = 5.9 Hz, 1 Hd), 6.78 (d, J = 7.7 Hz, 1 H), 7.19–7.36 (m, rotamer: 1H NMR (selected signals, 500 MHz, CDCl3): δ =
11 H) ppm. 13C NMR (125 MHz, CDCl3): δ = −5.5, −5.4, 17.3, −0.97 (m, 1 H), −0.34 (s, 3 H), −0.05 (s, 3 H), −0.04 (s, 3 H),
17.7, 18.2, 18.4, 19.5, 21.4, 23.3, 24.8, 25.9, 31.2, 31.4, 32.2, 0.32 (d, J = 6.6 Hz, 3 H), 0.79 (s, 9 H), 0.83 (s, 9 H), 0.98 (d, J =
36.1, 36.9, 49.4, 52.1, 53.4, 54.1, 54.5, 57.5, 57.8, 67.0, 67.7, 6.8 Hz, 3 H), 1.05 (d, J = 7.1 Hz, 3 H), 1.61–1.66 (m, 4 H), 2.19
81.3, 126.8, 128.1, 128.1, 128.2, 128.3, 128.5, 136.2, 136.8, (m, 1 H), 2.49 (m, 1 H), 2.73 (s, 3 H), 2.86 (dd, J = 7.3 Hz,
156.5, 168.4, 171.5, 172.0, 172.0, 172.1 ppm. HRMS (ESI): calcu- 3.5 Hz, 1 H), 3.01 (s, 3 H), 3.27 (s, 3 H), 3.68 (s, 3 H), 3.87 (m,
lated for C46H74N5O10Si [M + H]+ 884.5199, found 884.5206. 1 H), 4.59 (dd, J = 7.2 Hz, 3.5 Hz, 1 H), 5.04 (m, 1 H), 6.00–6.07
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
N-Alloc-(2S,3R)-{N′-(tert-prenyl)-3-[(tert-butyldimethylsilyl)oxy]- (m, 2 H), 6.72 (d, J = 7.4 Hz, 1 H), 7.35 (d, J = 8.8 Hz, 1 H), 7.85
tryptophanyl}-N-methyl-(2S,4R)-[5-(tert-butyldimethylsilyl)oxy- (d, J = 7.1 Hz, 1 H) ppm. 13C NMR (selected signals, 125 MHz,
leucyl]-(S)-alanyl-(2S,3R)-(3-methoxyphenylalanyl)-(S)-valyl-(S)- CDCl3): δ = −4.9, −4.7, 14.9, 17.3, 18.0, 18.2, 19.4, 21.3, 23.3,
N-methyl-leucine methyl ester (50a). To a solution of the 24.7, 25.6, 25.9, 27.9, 28.2, 29.7, 31.2, 31.8, 50.0, 54.2, 54.5,
methyl ester 39 (34.2 mg, 68.0 µmol) in methanol (700 µL) aq. 57.2, 59.0, 65.6, 68.3, 69.3, 81.4, 112.3, 114.0, 117.4, 119.6,
NaOH (1 M, 125 µL, 125 µmol) was added. The mixture was 121.1, 124.2, 126.9, 127.7, 132.8, 135.3, 136.9, 143.8,
allowed to warm to room temperature an stirring was contin- 156.4 ppm. LC-MS: Luna 3μ C18, 50 × 4.6 mm, 0.9 ml min−1,
ued for 2 d. After TLC showed complete conversion, pH-buffer MeCN/H2O gradient from 10% MeCN to 100% MeCN in
(1 mM phosphate buffer, pH 6.4) was added to the solution 5 min, 100% MeCN for 15 min, tR (50a) = 14.19 min, m/z =
and the solvent was evaporated in vacuo. 1255 ([M + Na]+). HRMS (ESI): calculated for C65H106N7O12Si2
The pentapeptide 49a (67 mg, 75.1 µmol) was dissolved in [M + H]+ 1232.7433, found 1232.7359.
methanol (1 mL) and 10% Pd/C (7 mg) was added under nitro- N-Alloc-(2S,3R)-{N′-(tert-prenyl)-3-[(tert-butyldimethylsilyl)oxy]-
gen atmosphere. The nitrogen was replaced by hydrogen and tryptophanyl}-(2S,4R)-[5-(tert-butyldimethylsilyl)oxy-leucyl]-(S)-
the mixture was stirred for 2–3 h at 1 atm until TLC showed alanyl-(2S,3R)-(3-methoxyphenylalanyl)-(S)-valyl-(S)-N-methyl-
complete conversion. The solution was filtered over celite and leucine methyl ester (50b). In analogy to the synthesis of 50a,
the solvent was removed in vacuo. The crude amine was dis- the methyl ester 39 (65.0 mg, 130 µL) was saponified with
solved in dry dichloromethane (1 mL) together with the crude 150 µL 1 N aq. NaOH and worked up using a buffer ( pH 6.4).
acid. The mixture was cooled down to −20 °C and DIPEA The pentapeptide 49b (117 mg, 132 µmol) was dissolved in
(12 µL, 71 µmol) followed by BEP (21.0 mg, 76.7 µmol) were methanol (1.5 mL) and 10% Pd/C (7.0 mg) was added under
added. The mixture was warmed up to room temperature over- nitrogen. The nitrogen was replaced by a hydrogen atmosphere
night and diluted with ethyl acetate (10 mL), after LCMS-analy- and the mixture was stirred until TLC showed complete con-
sis showed full conversion. The mixture was washed with 1 N version. After filtering over celite, the solvent was removed
KHSO4, sat. NaHCO3 and brine. The solvent was removed in vacuo. The crude amine was dissolved in dry dichloro-
in vacuo after drying over Na2SO4. Flash chromatography (4 g methane (1.5 mL) together with the buffer salt of the crude
C-18-silica, H2O/MeCN gradient) gave rise to the hexapeptide acid 39. The mixture was cooled to −20 °C and EDC·HCl
50a (46.1 mg, 37.4 µmol, 55%) as a colourless resin. If the reac- (25.0 mg, 132 µmol) and HOBt (3.5 mg, 24 µmol) were added.
tion is conducted with the purified acid 40, the peptide is The mixture was allowed to warm up to room temperature and
obtained in 69% yield (from 40). Rf (50a): 0.77 (dichloro- diluted with ethyl acetate (10 mL) after LC-MS-analysis showed
methane/diethyl ether 1 : 1). [α]20 D = −62.8 (c = 1.0, CHCl3). complete conversion. The solution was washed with 1 N aq.
Mixture of rotamers. Major rotamer: 1H NMR (500 MHz, KHSO4, sat. aq. NaHCO3 and brine. After drying over Na2SO4,
CDCl3): δ = −0.26 (s, 3 H), 0.00 (s, 3 H), 0.01 (s, 3 H), 0.10 (s, the solvent was removed in vacuo. Flash chromatography (4 g
3 H), 0.73 (d, J = 6.6 Hz, 3 H), 0.86 (s, 9 H), 0.91 (s, 9 H), C-18-silica, H2O/MeCN gradient) gave rise to the hexapeptide
0.86–0.96 (m, 12 H), 1.19 (m, 1 H), 1.21 (d, J = 7.1 Hz, 3 H), 50b (85.2 mg, 69.9 µmol, 54%) as a colourless resin. Rf (50b):
1.35 (m, 1 H), 1.48 (m, 1 H), 1.68 (s, 3 H), 1.69 (s, 3 H), 1.72 0.42 (ethyl acetate/petroleum ether 1 : 1). [α]20 D = −62.8 (c = 1.0,
(m, 2 H), 1.91 (m, 1 H), 2.10 (m, 1 H), 2.60 (s, 3 H), 2.96 (s, CHCl3). 1H NMR (500 MHz, CDCl3): δ = −0.07 (s, 3 H), 0.05 (s,
3 H), 3.30 (s, 3 H), 3.31 (m, 1 H), 3.37 (dd, J = 9.9 Hz, 4.9 Hz, 6 H), 0.07 (s, 3 H), 0.86–0.98 (m, 12 H), 0.89 (s, 9 H), 0.92 (s,
1 H), 3.68 (s, 3 H), 4.26 (m, 1 H), 4.45–4.57 (m, 3 H), 4.65 (dd, 9 H), 1.00 (d, J = 6.8 Hz, 3 H), 1.17 (d, J = 7.1 Hz, 3 H),
J = 7.6 Hz, 3.6 Hz, 1 H), 4.74–4.83 (m, 3 H), 5.03–5.38 (m, 6 H), 1.46–1.53 (m, 2 H), 1.66 (s, 3 H), 1.68 (s, 3 H), 1.68–1.79 (m,
5.65 (d, J = 5.3 Hz, 1 H), 5.89 (m, 1 H), 6.08 (dd, J = 17.4 Hz, 3 H), 1.95 (m, 1 H), 2.17 (m, 1 H), 3.01 (s, 3 H), 3.35 (s, 3 H),
10.5 Hz, 1 H), 6.84 (d, J = 7.6 Hz, 1 H), 7.00–7.09 (m, 3 H), 3.45 (dd, J = 10.0 Hz, 5.6 Hz, 1 H), 3.50 (dd, J = 10.0 Hz, 5.5 Hz,
7.15–7.29 (m, 5 H), 7.39 (d, J = 8.7 Hz, 1 H), 7.44 (d, J = 8.3 Hz, 1 H), 3.69 (s, 3 H), 4.23 (m, 1 H), 4.40 (m, 1 H), 4.51–4.54 (m,
1 H), 7.70 (d, J = 7.2 Hz, 1 H), 7.93 (d, J = 6.5 Hz, 1 H) ppm. 3 H), 4.69 (dd, J = 7.7 Hz, 3.5 Hz, 1 H), 4.81 (dd, J = 8.8 Hz,
13
C NMR (125 MHz, CDCl3): δ = −5.4, −5.4, −5.3, 17.2, 17.2, 6.3 Hz, 1 H), 4.89 (d, J = 3.5 Hz, 1 H), 5.08 (d, J = 17.4 Hz, 1 H),
17.3, 18.2, 18.3, 19.5, 21.4, 23.3, 24.8, 25.8, 25.9, 28.0, 28.2, 5.19 (d, J = 10.7 Hz, 1 H), 5.20 (m, 1 H), 5.27 (m, 1 H), 5.37 (dd,
29.1, 31.2, 31.4, 32.2, 36.9, 49.7, 52.0, 54.1, 54.5, 56.9, 57.4, J = 10.5 Hz, 5.3 Hz, 1 H), 5.58 (d, J = 6.3 Hz, 1 H), 5.70 (d, J =
57.5, 57.8, 59.1, 66.1, 67.4, 71.8, 81.0, 113.5, 113.6, 113.9, 2.7 Hz, 1 H), 5.88 (m, 1 H), 6.10 (dd, J = 17.4 Hz, 10.7 Hz, 1 H),
117.8, 119.4, 121.3, 121.5, 123.2, 126.8, 127.5, 128.2, 128.2, 6.71 (d, J = 6.7 Hz, 1 H), 6.78 (d, J = 7.6 Hz, 1 H), 7.02 (dd, J =
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6049
View Article Online
7.3 Hz, 7.3 Hz, 1 H), 7.08 (dd, J = 7.4 Hz, 7.3 Hz, 1 H), 137.0, 143.7, 155.6, 168.3, 168.5, 168.9, 169.7, 170.1, 170.2,
7.20–7.30 (m, 6 H), 7.34 (s, 1 H), 7.36 (d, J = 8.8 Hz, 1 H), 7.46 170.4, 171.1, 171.4, 171.5, 171.6, 171.9, 172.0, 172.1 ppm. (Car-
(d, J = 7.3 Hz, 1 H), 7.56 (d, J = 7.3 Hz, 1 H) ppm. 13C NMR bonyl signals not distinguishable from the rotameric signals).
(125 MHz, CDCl3): δ = −5.3, −5.4, −4.8, 17.1, 17.4, 17.8, 18.2, Minor rotamer 1H NMR (selected signals, 500 MHz, CDCl3):
18.3, 19.5, 21.4, 23.3, 24.8, 25.7, 26.0, 28.0, 31.2, 31.3, 32.2, δ = −1.05 (m, 1 H), −0.34 (s, 3 H), −0.02 (s, 3 H), 0.00 (s, 3 H),
36.1, 37.0, 49.5, 51.9, 52.1, 54.3, 54.5, 57.5, 57.8, 59.2, 61.0, 0.01 (s, 3 H), 0.32 (d, J = 6.6 Hz, 3 H), 0.80 (s, 9 H), 0.86 (s,
66.0, 67.6, 68.6, 81.2, 113.1, 113.5, 113.9, 118.0, 119.0, 119.2, 9 H), 1.12 (d, J = 7.1 Hz, 3 H), 1.60 (m, 1 H), 2.44 (m, 1 H), 2.78
120.9, 124.0, 126.8, 126.9, 128.1, 128.3, 132.5, 135.5, 137.1, (s, 3 H), 2.86 (m, 1 H), 2.99 (s, 3 H), 3.32 (s, 3 H), 3.69 (s, 3 H),
143.9, 156.5, 168.6, 168.9, 171.4, 171.7, 172.0, 172.2 ppm. 3.87 (m, 1 H), 4.02 (m, 1 H), 4.59 (dd, J = 7.2 Hz, 3.5 Hz, 1 H),
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
LC-MS: Luna 3μ C18, 50 × 4.6 mm, 0.9 ml min−1, MeCN/H2O 4.97 (d, J = 9.4 Hz, 1 H), 7.32 (d, J = 8.1 Hz, 1 H), 7.44 (d, J = 8.5
gradient from 10% MeCN to 100% MeCN in 5 min, 100% Hz, 1 H), 7.68 (d, J = 8.5 Hz, 1 H) ppm. 13C NMR (selected
MeCN for 15 min, tR (50b) = 13.76 min, m/z = 1241 ([M + Na]+). signals, 125 MHz, CDCl3): δ = −4.9, −4.8, 15.0, 19.5, 24.8, 25.7,
HRMS (ESI): calculated for C64H104N7O12Si2 [M + H]+ 28.2, 31.8, 49.4, 52.1, 54.0, 54.5, 55.6, 65.6, 68.3, 69.2, 81.4,
1218.7276, found 1218.7254. 113.6, 114.0, 117.9, 119.4, 119.5, 124.2, 124.9, 127.0, 127.6,
N-Alloc-(2S,3R)-(2-amino-3,5-dimethylhex-4-enoyl)-(2S,3R)- 128.1, 128.3, 132.8, 133.8, 135.4, 136.8, 143.8, 155.8 ppm.
(2-amino-3,5-dimethylhex-4-enoyl)-(2S,3R)-{N′-(tert-prenyl)-3- LC-MS: Luna 3μ C18, 50 × 4.6 mm, 0.9 ml min−1, MeCN/H2O
[(tert-butyldimethylsilyl)oxy]-tryptophanyl}-N-methyl-(2S,4R)- gradient from 10% MeCN to 100% MeCN in 5 min, 100%
[5-(tert-butyldimethylsilyl)oxy-leucyl]-(S)-alanyl-(2S,3R)-(3-methoxy- MeCN for 15 min, tR (51a) = 15.57 min, m/z = 1394 ([M + Na]+).
phenylalanyl)-(S)-valyl-(S)-N-methyl-leucine methyl ester (51a). To HRMS (ESI): calculated for C73H118N8O13Si2Na [M + Na]+
a solution of the hexapeptide 50a (101 mg, 81.9 µmol) in a 1393.8249, found 1393.8240.
mixture of acetonitrile (500 µL) and water (400 µL) TPPTS N-Alloc-(2S,3R)-(2-amino-3,5-dimethylhex-4-enoyl)-(2S,3R)-
(1.9 mg, 3.2 µmol), Pd(OAc)2 (20 mM in MeCN, 80 µL, (2-amino-3,5-dimethylhex-4-enoyl)-(2S,3R)-{N′-(tert-prenyl)-3-
1.6 µmol) and diethylamine (42 µL, 410 µmol) were sub- [(tert-butyldimethylsilyl)oxy]-tryptophanyl}-(2S,4R)-[5-(tert-
sequently added. After stirring for 90 min at room temperature butyldimethylsilyl)oxy-leucyl]-(S)-alanyl-(2S,3R)-(3-methoxyphenyl-
(LC-MS-analysis), the solvent was removed in vacuo and the alanyl)-(S)-valyl-(S)-N-methyl-leucine methyl ester (51b). In
residue was dissolved in dry dichloromethane (1.2 mL). To the analogy to the synthesis of 51a, the hexapeptide 50b (75.0 mg,
resulting solution the acid (2S,3R)-5 (21.7 mg, 90.0 µmol) was 61.6 µmol) was dissolved in a mixture of acetonitrile (500 µL)
added, followed by HOBt (11.7 mg, 34.0 µmol) and EDC·HCl and water (300 µL) and was deprotected and worked up using
(18.9 mg, 98.6 µmol) at 0 °C. The mixture was allowed to warm TPPTS (2.3 mg, 4 µmol), Pd(OAc)2 (20 mM in MeCN, 100 µL,
to room temperature and was diluted with ethyl acetate (5 mL) 2 µmol) and diethylamine (32 µL, 310 µmol). The obtained
after LC-MS-analysis showed full conversion. The resulting residue was dissolved in dry dichloromethane (800 µL). To this
solution was washed with water, sat aq. NaHCO3 and brine. solution the acid (2S,3R)-5 (16.4 mg, 68.2 µmol), HOBt
The organic layer was dried over Na2SO4 and the solvent was (8.4 mg, 62.2 µmol) and EDC·HCl (13.1 mg, 68.2 µmol) were
removed in vacuo. Flash chromatography (4 g C-18-silica, H2O/ added at 0 °C. The mixture was allowed to warm to room temp-
MeCN gradient) gave rise to the heptapeptide 51a (100 mg, erature and was diluted with ethyl acetate (5 mL), after LC-MS-
72.9 µmol, 89%) as a colourless resin. Rf (51a): 0.60 (dichloro- analysis showed full conversion. The mixture was washed with
methane/diethyl ether 1 : 1). [α]20 D = −47.0 (c = 1.0, CHCl3). water, sat. NaHCO3 and brine. The solvent was removed
Mixture of rotamers. Major rotamer: 1H NMR (500 MHz, in vacuo after drying over Na2SO4. Flash chromatography (4 g
CDCl3): δ = −0.26 (s, 3 H), −0.05 (s, 3 H), −0.03 (s, 3 H), 0.10 (s, C-18-silica, H2O/MeCN gradient) gave rise to the heptapeptide
3 H), 0.83 (s, 9 H), 0.93 (s, 9 H), 0.77–0.99 (m, 15 H), 1.07 (d, 51b (65.1 mg, 47.9 µmol, 78%) as a colourless resin. Rf (51b):
J = 6.3 Hz, 3 H), 1.19 (m, 1 H), 1.23 (d, J = 7.1 Hz, 3 H), 1.40 (m, 0.56 (ethyl acetate/petroleum ether 1 : 1).[α]20 D = −73.5 (c = 1.0,
1 H), 1.48 (m, 1 H), 1.56 (s, 3 H), 1.65 (s, 3 H), 1.68 (s, 3 H), CHCl3). 1H NMR (500 MHz, CDCl3): δ = −0.09 (s, 3 H), 0.03 (s,
1.68 (s, 3 H), 1.73 (m, 2 H), 1.96 (m, 1 H), 2.12 (m, 1 H), 2.57 3 H), 0.04 (s, 3 H), 0.06 (s, 3 H), 0.56 (d, J = 6.8 Hz, 1 H),
(s, 3 H), 2.86 (m, 1 H), 2.97 (s, 3 H), 3.27 (s, 3 H), 3.31 (m, 2 H), 0.86–0.94 (m, 6 H), 0.88 (s, 9 H), 0.92 (s, 9 H), 0.98 (d, J = 6.4
3.68 (s, 3 H), 4.16 (m, 1 H), 4.26 (m, 1 H), 4.51–4.68 (m, 4 H), Hz, 3 H), 1.01 (d, J = 6.8 Hz, 3 H), 1.06 (d, J = 6.6 Hz, 3 H), 1.19
4.73–4.82 (m, 3 H), 4.94 (d, J = 11.0 Hz, 1 H), 5.05–5.40 (m, (d, J = 7.2 Hz, 3 H), 1.48 (s, 3 H), 1.49–1.58 (m, 2 H), 1.59 (s, 3
6 H), 5.53 (d, J = 10.0 Hz, 1 H), 5.92 (m, 1 H), 6.07 (m, 1 H), H), 1.68 (s, 3 H), 1.70 (s, 3 H), 1.74 (m, 2 H), 1.90–1.99 (m, 2
6.68 (bs, 1 H), 6.76 (d, J = 7.5 Hz, 1 H), 7.00–7.09 (m, 3 H), H), 2.30 (m, 1 H), 2.77 (m, 1 H), 3.03 (s, 3 H), 3.35 (s, 3 H), 3.36
7.13–7.27 (m, 5 H), 7.35 (d, J = 8.6 Hz, 1 H), 7.45 (d, J = 8.2 Hz, (m, 1 H), 3.60 (dd, J = 4.2 Hz, 9.8 Hz, 1 H), 3.68 (s, 3 H), 3.86
1 H), 7.82 (d, J = 7.6 Hz, 1 H), 8.34 (d, J = 5.9 Hz, 1 H) ppm. (m, 1 H), 4.15 (m, 1 H), 4.40 (m, 1 H), 4.54 (dd, J = 13.0 Hz, 5.9
13
C NMR (125 MHz, CDCl3): δ = −5.4, −5.4, −5.3, −5.2, 17.2, Hz, 1 H), 4.62 (dd, J = 6.1 Hz, 1.6 Hz, 1 H), 4.66–4.70 (m, 2 H),
17.2, 17.3, 17.4, 18.0, 18.0, 18.2, 19.5, 21.4, 23.3, 24.7, 25.7, 4.79 (dd, J = 8.8 Hz, 7.5 Hz, 1 H), 4.82 (d, J = 9.3 Hz, 1 H), 5.03
25.8, 25.9, 28.0, 28.2, 29.2, 21.2, 31.2, 31.4, 32.2, 35.8, 37.0, (d, J = 2.2 Hz, 1 H), 5.09 (d, J = 17.3 Hz, 1 H), 5.11 (bs, 1 H),
49.9, 52.1, 54.1, 54.4, 56.5, 57.4, 57.5, 57.8, 59.0, 59.1, 65.9, 5.19 (d, J = 10.7 Hz, 1 H), 5.30–5.40 (m, 3 H), 5.82 (d, J = 1.6
67.1, 72.0, 81.1, 112.2, 113.7, 114.0, 117.9, 119.4, 121.1, 121.4, Hz, 1 H), 5.96 (m, 1 H), 6.06 (dd, J = 17.3 Hz, 10.7 Hz, 1 H),
123.2, 124.5, 126.8, 127.4, 128.2, 128.2, 132.7, 134.6, 135.9, 6.99 (m, 1 H), 7.05–7.12 (m, 4 H), 7.18–7.28 (m, 5 H), 7.36 (s,
6050 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
1 H), 7.43–7.46 (m, 3 H), 7.70 (d, J = 7.8 Hz, 1 H) ppm. 13C 28.2, 29.2, 29.4, 30.9, 31., 32.0, 35.1, 39.0, 50.1, 55.7, 55.9, 56.5,
NMR (125 MHz, CDCl3): δ = −5.4, −5.4, −5.0, 15.7, 17.0, 17.5, 57.7, 57.8, 58.6, 58.7, 59.0, 68.2, 72.1, 79.8, 112.0, 113.7, 114.1,
17.8, 18.0, 18.1, 18.3, 19.5, 21.5, 23.3, 24.7, 25.8, 25.9, 26.0, 118.1, 119.3, 121.3, 123.0, 124.8, 127.4, 127.8, 128.2, 128.6,
27.9, 28.0, 30.7, 31.3, 32.1, 33.3, 36.1, 37.2, 49.5, 52.0, 52.7, 134.6, 135.2, 135.9, 143.6, 168.0, 168.2, 169.1, 169.5, 170.6,
54.5, 54.7, 57.5, 58.2, 59.1, 61.0, 61.2, 66.7, 67.3, 68.5, 81.3, 171.4, 172.4 ppm. LC-MS: Luna 3μ C18, 50 × 4.6 mm, 0.9 ml
113.7, 114.0, 114.2, 119.0, 119.2, 119.4, 121.2, 122.8, 123.9, min−1, 100% MeCN, tR (52a) = 14.50 min, m/z = 1278
127.0, 127.0, 127.7, 128.2, 131.9, 135.3, 135.8, 138.0, 143.7, ([M + Na]+). HRMS (ESI): calculated for C68H111N8O10Si2
157.3, 169.4, 170.2, 171.6, 171.9, 172.1, 172.4, 172.6 ppm. [M + H]+ 1255.7956, found 1255.7938.
LC-MS: Luna 3μ C18, 50 × 4.6 mm, 0.9 ml min−1, MeCN/H2O O-O′-Bis-(tert-butyldimethylsilyl)-cyclomarin D (52b). In
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
gradient from 10% MeCN to 100% MeCN in 5 min, 100% analogy to the synthesis of 52a, the linear heptapeptide 51b
MeCN for 15 min, tR (51b) = 15.42 min, m/z = 1383 ([M + Na]+). (58.0 mg, 42.7 µmol) was dissolved in methanol (500 µL) and
HRMS (ESI): calculated for C72H117N8O13Si2 [M + H]+ saponified using 1 M NaOH (50 µl, 50 µmol). The reaction was
1357.8273, found 1357.8279. worked up as described, after TLC showed full conversion
O-O′-Bis-(tert-butyldimethylsilyl)-cyclomarin C (52a). The (48 h). The N-terminal deprotection was also conducted as
linear heptapeptide 51a (97.0 mg, 70.7 µmol) was dissolved in described, using 20 mM Pd(OAc)2 (50µL, 1 µmol), TPPTS
methanol (1 mL) and aq. NaOH (1 M, 80 µL, 80 µmol) was (1.2 mg, 2 µmol) and diethylamine (22 µL, 214 µmol) in a
added. The mixture was stirred for 2 d at room temperature. mixture of acetonitrile (300 µL) and phosphate buffer ( pH 6.4,
The solvent was removed in vacuo and taken up in acetonitrile 200 µL). The residue was dissolved in dry dichloromethane
(400 µL) and 1 mM phosphate buffer ( pH 6.4, 350 µL). To the (10 mL) and added to a solution of PyBOP (47.0 mg,
resulting solution TPPTS (1.6 mg, 2.8 µmol), Pd(OAc)2 (20 mM 90.3 µmol) and DIPEA (16 µL, 92 µmol) in dry dichloro-
in MeCN, 70 µL, 1.4 µmol) and diethylamine (37 µL, methane (30 mL) via a syringe pump over a period of 12 h.
360 µmol) were added at room temperature. After stirring for After stirring for 18 h in total, the solvent was removed
2 h at room temperature (LC-MS-analysis), the solvent was in vacuo and flash chromatography (4 g C-18-silica, H2O/MeCN
removed via lyophilisation. The obtained residue was dissolved gradient) gave rise to the cyclic heptapeptide 52b (24.3 mg,
in dry dichloromethane (25 mL). 19.6 µmol, 46%) as a colourless resin. Rf (52b): 0.71 (ethyl
D = −83.2 (c = 1.0, CHCl3). H NMR (500 MHz,
acetate). [α]20 1
PyBOP (73.9 mg, 140 µmol) and DIPEA (24 µL, 140 µmol)
were dissolved in dry dichloromethane (55 mL) in a three- CDCl3): δ = −0.30 (s, 3 H), −0.16 (s, 3 H), 0.02 (s, 3 H), 0.03 (s,
necked-flask with pressure equalization. The solution of the 3 H), 0.79–1.00 (m, 18 H), 0.88 (s, 9 H), 0.90 (s, 9 H), 1.24–1.34
peptide was added with a syringe pump to the coupling (m, 9 H), 1.37 (d, J = 7.2 Hz, 3 H), 1.59 (s, 3 H), 1.67 (m, 1 H),
reagent over a period of 12 h. After the addition was complete, 1.76 (s, 3 H), 1.81 (s, 3 H), 1.82–1.93 (m, 3 H), 2.03 (m, 1 H),
stirring was continued for additional 6 h. The solvent was 3.29 (s, 3 H), 3.42 (dd, J = 10.0 Hz, 5.1 Hz, 1 H), 3.48 (dd, J =
removed in vacuo and flash chromatography (4 g C-18-silica, 10.0 Hz, 4.9 Hz, 1 H), 3.86 (m, 1 H), 3.94 (m, 1 H), 4.34 (dd, J =
H2O/MeCN gradient) gave rise to the cyclic heptapeptide 52a 2.4 Hz, 2.4 Hz, 1 H), 4.36 (m, 1 H), 4.51–4.72 (m, 2 H), 4.77 (d,
(67.2 mg, 53.5 µmol, 76% from 51a) as a colourless resin. Rf J = 9.6 Hz, 1 H), 4.96 (d, J = 4.8 Hz, 1 H), 4.98 (m, 1 H), 5.21 (d,
(52a): 0.60 (dichloromethane/diethyl ether 3 : 2). [α]20 D = −70.1 J = Hz, 1 H), 5.25 (d, J = 10.7 Hz, 1 H), 5.66 (d, J = 2.4 Hz, 1 H),
(c = 1.0, CHCl3). 1H NMR (500 MHz, CDCl3): δ = −1.02 (ddd, J = 5.90 (bs, 1 H), 6.17 (dd, J = 17.6 H, 10.7 Hz, 1 H), 7.07 (m, 1 H),
13.0 Hz, 10.1 Hz, 2.8 Hz, 1 H), −0.30 (s, 3 H), −0.07 (s, 3 H), 7.12 (m, 1 H), 7.17–7.49 (m, 11 H), 7.60 (d, J = 7.9 Hz, 1 H),
−0.05 (s, 3 H), 0.13 (s, 3 H), 0.16 (d, J = 6.6 Hz, 3 H), 0.67 (d, J = 7.78 (bs, 1 H) ppm. 13C NMR (125 MHz, CDCl3): δ = −5.5, −5.4,
6.5 Hz, 3 H), 0.81 (s, 9 H), 0.92 (s, 9 H), 0.96 (d, J = 6.7 Hz, −4.9, 16.8, 17.2, 18.2, 18.3, 18.9, 18.9, 21.6, 23.4, 24.6, 25.8,
3 H), 0.98 (d, J = 5.7 Hz, 3 H), 0.99 (d, J = 5.8 Hz, 3 H), 1.01 (m, 25.9, 25.9, 27.7, 27.9, 29.7, 30.2, 32.5, 33.2, 35.8, 36.2, 50.4,
1 H), 1.08 (d, J = 6.6 Hz, 3 H), 1.19 (m, 1 H), 1.26 (d, J = 7.5 Hz, 52.7, 54.9, 55.8, 57.5, 59.0, 59.2, 62.3, 67.9, 68.7, 80.5, 113.6,
3 H), 1.28 (s, 3 H), 1.54 (ddd, J = 13.0 Hz, 13.0 Hz, 4.5 Hz, 1 H), 113.7, 113.8, 119.2, 119.4, 121.4, 123.7, 125.8, 126.5, 127.9,
1.62 (s, 3 H), 1.63–1.73 (m, 3 H), 1.65 (s, 3 H), 1.74 (s, 3 H), 128.3, 133.9, 136.0, 136.8, 143.9, 168.8, 169.0, 170.6, 171.3,
2.26 (m, 1 H), 2.41 (ddd, J = 13.1 Hz, 11.7 Hz, 4.3 Hz, 1 H), 2.47 171.5, 171.9, 172.6 ppm. LC-MS: Luna 3μ C18, 50 × 4.6 mm,
(m, 1 H), 2.49 (s, 3 H), 2.84 (m, 1 H), 2.87 (s, 3 H), 3.36 (s, 3 H), 0.9 ml min−1, 100% MeCN, tR (52b) = 9.87 min, m/z = 1264
4.06 (dd, J = 10.6 Hz, 9.5 Hz, 1 H), 4.34 (dd, J = 9.1 Hz, 9.1 Hz, ([M + Na]+). HRMS (ESI): calculated for C67H109N8O10Si2
1 H), 4.40 (dd, J = 9.1 Hz, 1.7 Hz, 1 H), 4.52 (dd, J = 11.9 Hz, [M + H]+ 1241.7800, found 1241.7739.
2.6 Hz, 1 H), 4.69–4.77 (m, 2 H), 4.81 (dd, J = 4.8 Hz, 4.8 Hz,
1 H), 5.01–5.08 (m, 2 H), 5.09 (d, J = 4.8 Hz, 1 H), 5.18 (d, J = Cyclomarin C
10.7 Hz, 1 H), 5.21 (d, J = 9.1 Hz, 1 H), 6.03 (dd, J = 17.4 Hz, To a solution of the protected, cyclic heptapeptide 52a
10.7 Hz, 1 H), 6.45 (d, J = 1.7 Hz, 1 H), 6.98–7.02 (m, 2 H), 7.06 (50.0 mg, 39.8 µmol) in methanol (400 µL) NH4F (14.8 mg,
(m, 1 H), 7.17–7.19 (m, 3 H), 7.21–7.27 (m, 3 H), 7.43 (d, J = 8.4 400 µmol) was added at 0 °C. The mixture was warmed to
Hz, 1 H), 7.71 (d, J = 7.8 Hz, 1 H), 7.87 (d, J = 9.1 Hz, 1 H), 7.98 room temperature overnight and carefully heated to 40 °C
(d, J = 9.4 Hz, 1 H), 8.18 (d, J = 10.6 Hz, 1 H) ppm. 13C NMR (bath temperature) for an additional 18 h. The solvent was
(125 MHz, CDCl3): δ = −5.4, −5.4, −5.3, −4.9, 15.3, 18.1, 18.3, removed in vacuo after LC-MS-analysis showed complete con-
18.4, 18.8, 19.5, 20.0, 20.5, 22.1, 23.6, 25.4, 25.8, 25.9, 28.0, version. The residue was dissolved in THF (400 µL) at 0 °C and
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6051
View Article Online
TBAF (1 M in THF, 44 µL, 44 µmol) was added. After stirring (m, 4 H), 7.66 (d, J = 7.7 Hz, 1 H), 7.79 (d, J = 7.4 Hz, 1 H) ppm.
for 30 min at this temperature, the solvent was removed at 13
C NMR (125 MHz, CDCl3): δ = 17.0, 17.9, 18.0, 18.6, 19.2,
0 °C and the residue was purified by preparative HPLC (Luna, 21.4, 23.3, 25.8, 25.8, 27.7, 27.8, 30.3, 30.5, 32.3, 33.0, 36.0,
100 mm/10 mm/5 µ, 5 mL min−1, H2O/MeCN 45 : 55). Cyclo- 36.4, 36.5, 51.5, 52.2, 55.3, 55.8, 57.4, 59.2, 67.3, 68.2, 81.0,
marin C (27.2 mg, 26.5 µmol, 67%) was obtained as a white 112.6, 113.5, 114.0, 119.1, 119.3, 121.3, 123.3, 125.4, 127.0,
solid. Rf (cyclomarin C): 0.71 (ethyl acetate). [α]20D = −30.4 (c = 127.6, 128.4, 128.4, 133.9, 136.0, 136.6, 144.1, 169.7, 170.3,
1.0, CHCl3). 1H NMR (500 MHz, CDCl3): δ = 0.56 (ddd, J = 13.8 171.1, 172.2, 172.6, 172.8, 173 ppm. LC-MS: Luna 3μ C18, 50 ×
Hz, 6.4 Hz, 3.1 Hz, 1 H), 0.64 (d, J = 6.5 Hz, 3 H), 0.70 (d, J = 4.6 mm, 0.9 ml min−1, MeCN/H2O 1 : 9 to 100% MeCN in
6.8 Hz, 3 H), 0.84 (d, J = 6.6 Hz, 3 H), 0.89 (d, J = 6.6 Hz, 3 H), 5 min, 100% MeCN, tR (cyclomarin D) = 7.75 min, m/z = 1026
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
0.94 (d, J = 6.7 Hz, 3 H), 1.04 (m, 1 H), 1.06 (d, J = 6.7 Hz, 3 H), ([M + Na]+), 996 ([M − OH]+). HRMS (ESI): calculated for
1.25 (s, 3 H), 1.29 (d, J = 7.3 Hz, 3 H), 1.38–1.44 (m, 2 H), 1.68 C55H81N8O10 [M + H]+ 1013.6070, found 1013.6022.
(m, 1 H), 1.70 (s, 6 H), 1.72 (s, 3 H), 2.18–2.32 (m, 4 H), 2.70 (s,
3 H), 2.82 (s, 3 H), 2.47 (dd, J = 11.1 Hz, 5.6 Hz, 1 H), 2.84 (dd,
J = 11.1 Hz, 4.3 Hz, 1 H), 3.36 (s, 3 H), 4.10 (dd, J = 10.5 Hz, 9.8
Hz, 1 H), 4.38 (dd, J = 8.7 Hz, 8.7 Hz, 1 H), 4.57 (dd, J = 4.9 Hz, Acknowledgements
4.9 Hz, 1 H), 4.74–4.79 (m, 2 H), 4.80–4.87 (m, 1 H), 4.89 (dd,
Financial support from the Deutsche Forschungsgemeinschaft
J = 4.8 Hz, 4.8 Hz, 1 H), 5.07 (d, J = 5.4 Hz, 1 H), 5.16 (d, J =
was gratefully acknowledged. We are especially thankful to
17.4 Hz, 1 H), 5.21 (d, J = 10.7 Hz, 1 H), 5.30 (d, J = 4.9 Hz,
Marie Schneefeld from Hannover Medical School for investi-
1 H), 6.06 (dd, J = 17.4 Hz, 10.7 Hz, 1 H), 6.85 (d, J = 4.9 Hz,
gating the biological activities of the cyclomarins.
1 H), 7.04 (ddd, J = 7.2 Hz, 0.8 Hz, 1 H), 7.08–7.13 (m, 2 H),
7.19 (m, 2 H), 7.22–7.26 (m, 3 H), 7.29 (s, 1 H), 7.49 (d, J = 7.2
Hz, 1 H), 7.56 (d, J = 7.9 Hz, 1 H), 7.94 (d, J = 8.7 Hz, 1 H), 8.06
(d, J = 9.5 Hz, 1 H), 8.18 (d, J = 10.5 Hz, 1 H) ppm. 13C NMR References
(125 MHz, CDCl3): δ = 17.6, 18.5, 18.9, 19.3, 20.0, 20.8, 22.4,
23.4, 25.0, 25.7, 27.8, 27.9, 29.3, 29.6, 30.8, 33.0, 33.3, 35.5, 1 Fact Sheet Tuberkulose, WHO, http://www.who.int/media-
38.9, 50.6, 53.0, 55.3, 55.9, 57.7, 58.1, 58.6, 59.2, 59.2, 66.3, centre/factsheets/fs104/en/.
68.6, 80.0, 111.3, 113.8, 114.3, 118.9, 119.5, 121.5, 123.1, 124.8, 2 P. E. A. da Silva and J. C. Palomino, J. Antimicrob.
126.8, 127.8, 128.3, 128.7, 134.4, 135.1, 135.8, 143.7, 168.4, Chemother., 2011, 66, 1417–1430.
168.9, 169.6, 170.6, 170.9, 171.6, 172.5 ppm. LC-MS: Luna 3μ 3 Global Tuberculosis Report 2014, WHO, http://www.who.int/
C18, 50 × 4.6 mm, 0.9 ml min−1, MeCN/H2O 1 : 1, tR (cyclo- tb/publications/global_report/en/.
marin C) = 7.12 min, m/z = 1050 ([M + Na]+), 1010 ([M − OH]+). 4 (a) F. von Nussbaum, M. Brands, B. Hinzen, S. Weigand
HRMS (ESI): calculated for C56H83N8O10 [M + H]+ 1027.6227, and D. Häbich, Angew. Chem., 2006, 31, 5194–5254, (Angew.
found 1027.6242. Chem., Int. Ed., 2006, 45, 5072–5129); (b) C. B. Ford,
P. L. Lin, M. R. Chase, R. R. Shah, O. Iartchouk, J. Galagan,
Cyclomarin D N. Mohaideen, T. R. Loerger, J. C. Sacchettini, M. Lipsitch,
The cyclic heptapeptide 52b (21.0 mg, 16.9 µmol) was de- J. L. Flynn and S. M. Fortune, Nat. Genet., 2011, 43, 482–
protected and worked up as described for cyclomarin C using 486; (c) J. T. Hodgkinson, H. F. Sore, M. Welch,
NH4F (6.6 mg, 170 µmol) in methanol (200 µL) at 40 °C. The G. P. C. Salmond and D. R. Spring, Angew. Chem., 2013, 41,
solvent was removed after LC-MS-analysis showed full conver- 10904–10932, (Angew. Chem., Int. Ed., 2013, 52, 10706–
sion. The residue was dissolved in THF (200 µL) at 0 °C and 10733).
TBAF (1 M in THF, 20 µL, 20 µmol) was added. The mixture 5 (a) D. L. Clemens and M. A. Wolowitz, J. Exp. Med., 1995,
was stirred for 45 min and the solvent was evaporated at 0 °C. 181, 257–270; (b) V. Deretic, S. Singh, S. Master, J. Harris,
Preparative HPLC (Luna, 100 mm/10 mm/5 µ, 5 mL min−1, E. Roberts, G. Kyei, A. Davis, S. de Haro, J. Naylor, H. Lee
H2O/MeCN 45 : 55) gave rise to cyclomarin D (11.0 mg, and I. Verne, Cell. Microbiol., 2006, 8, 719–727.
10.9 µmol, 64%) as a colourless solid. [α]20 D = −24.4 (c = 1.0, 6 (a) K. Duncam and C. E. Barry III, Curr. Opin. Microbiol.,
CHCl3). 1H NMR (500 MHz, CDCl3): δ = 0.66 (d, J = 6.6 Hz, 2004, 7, 460–465; (b) D. B. Young, M. D. Perkins,
3 H), 0.86–0.90 (m, 6 H), 0.91 (d, J = 6.6 Hz, 3 H), 0.94 (d, J = K. Duncan and C. E. Barry III, J. Clin. Invest., 2008, 118,
6.5 Hz, 3 H), 1.01 (d, J = 6.6 Hz, 3 H), 1.26 (s, 3 H), 1.35 (m, 1255–1265.
1 H), 1.39 (d, J = 7.2 Hz, 3 H), 1.50 (m, 1 H), 1.55 (s, 3 H), 1.62 7 (a) W. R. McClure and C. L. Cech, J. Biol. Chem., 1978, 253,
(m, 1 H), 1.76 (s, 3 H), 1.78 (m, 3 H), 1.79–1.84 (m, 4 H), 2.08 8949–8956; (b) R. Rawat, A. Whitty and P. J. Tonge, Proc.
(m, 1 H), 2.39 (s, 3 H), 2.69 (m, 1 H), 3.28 (s, 3 H), 3.34 (m, Natl. Acad. Sci. U. S. A., 2003, 100, 13881–13886;
1 H), 3.54 (m, 1 H), 3.91 (m, 1 H), 4.12 (m, 1 H), 4.19–4.25 (m, (c) Y. Zhang, Annu. Rev. Pharmacol. Toxicol., 2005, 45, 529–
2 H), 4.40 (bs, 1 H), 4.52–4.61 (m, 2 H), 4.74 (d, J = 9.3 Hz, 564.
1 H), 4.93 (d, J = 4.0 Hz, 1 H), 5.00 (m, 1 H), 5.20–5.23 (m, 2 H), 8 M. K. Renner, Y. C. Shen, X. C. Cheng, P. R. Jensen,
5.61 (bs, 1 H), 6.15 (dd, J = 17.6 Hz, 10.7 Hz, 1 H), 6.32 (bs, W. Frankmoelle, C. A. Kauffman, W. Fenical, E. Lobkovsky
1 H), 7.03–7.15 (m, 3 H), 7.24–7.39 (m, 5 H), 7.44–7.50 and J. Clardy, J. Am. Chem. Soc., 1999, 121, 11273–11276.
6052 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016
View Article Online
9 E. A. Gontang, W. Fenical and P. R. Jensen, Appl. Environ. Org. Lett., 2003, 5, 2631–2633; (c) J. Deska and U. Kazmaier,
Microbiol., 2007, 73, 3272–3282. Curr. Org. Chem., 2008, 12, 355–385.
10 C. J. Pazoles and S. A. Siegel, US-Patent US5759995A, 1998. 25 (a) R. Grandel and U. Kazmaier, Tetrahedron Lett., 1997, 38,
11 (a) E. K. Schmitt, N. Riwanto, V. Sambandamurthy, 8009–8012; (b) U. Kazmaier and R. Grandel, Eur. J. Org.
S. Roggo, C. Miault, C. Zwingelstein, P. Krastel, C. Noble, Chem., 1998, 1833–1840; (c) R. Grandel, U. Kazmaier and
D. Beer, S. P. S. Rao, M. Au, P. Niyomrattanakit, V. Lim, F. Rominger, J. Org. Chem., 1998, 63, 4524–4528.
J. Zheng, D. Jeffery, K. Pethe and L. R. Camacho, Angew. 26 (a) M. Pohlman and U. Kazmaier, Org. Lett., 2003, 5, 2631–
Chem., 2011, 123, 6011–6013, (Angew. Chem., Int. Ed., 2011, 2633; (b) M. Pohlman, U. Kazmaier and T. Lindner, J. Org.
50, 5889–5891); (b) D. Vasudevan, S. P. S. Rao and Chem., 2004, 69, 6909–6912; (c) B. Mendler and
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
C. G. Noble, J. Biol. Chem., 2013, 43, 30883–30981. U. Kazmaier, Org. Lett., 2005, 7, 1715–1718; (d) C. Schmidt
12 L. G. Wayne and L. G. Hayes, Infect. Immun., 1996, 64, and U. Kazmaier, Eur. J. Org. Chem., 2008, 887–894.
2062–2069. 27 (a) U. Kazmaier and M. Pohlman, Synlett, 2004, 623–626;
13 N. Buerstner, S. Roggo, N. Ostermann, J. Blank, C. Delmas, (b) U. Kazmaier, J. Deska and A. Watzke, Angew. Chem.,
F. Freuler, B. Gerhartz, A. Hinninger, D. Hoepfner, 2006, 118, 4973–4976, (Angew. Chem., Int. Ed., 2006, 45,
B. Liechty, M. Mihalic, J. Murphy, D. Pistorius, 4855–4858); (c) J. Deska and U. Kazmaier, Angew. Chem.,
M. Rottmann, J. R. Thomas, M. Schirle and E. K. Schmitt, 2007, 119, 4654–4657, (Angew. Chem., Int. Ed., 2007, 46,
ChemBioChem, 2015, 16, 2433–2436. 4570–4573); (d) J. Deska and U. Kazmaier, Chem. – Eur. J.,
14 (a) A. Isogai, J. Nakayama, S. Takayama, A. Kusai and 2007, 13, 6204–6211; (e) U. Kazmaier, D. Stolz, K. Krämer
A. Suzuki, Biosci., Biotechnol., Biochem., 1992, 56, 1079– and F. Zumpe, Chem. – Eur. J., 2008, 14, 1322–1329.
1085; (b) K. Ueda, J. Z. Xiao, N. Doke and S. Nakatsuka, 28 S.-J. Wen and Z.-J. Yao, Org. Lett., 2004, 6, 2721–2724.
Tetrahedron Lett., 1992, 33, 5377–5380. 29 P. Barbie and U. Kazmaier, Org. Lett., 2016, 18, 204–207.
15 H. Tada, T. Tozyo, Y. Terui and F. Hayashi, Chem. Lett., 30 (a) U. Kazmaier and S. Maier, Tetrahedron, 1996, 52, 941–
1992, 21, 431–434. 954; (b) A. Krebs and U. Kazmaier, Tetrahedron Lett., 1996,
16 (a) T. Takita, K. Oki, Y. Okami, K. Maeda and H. Umezawa, 37, 7945–7946; (c) U. Kazmaier and C. Schneider, Synlett,
J. Antibiot., Ser. A, 1962, 15, 46–48; (b) T. Takita, J. Antibiot., 1996, 975–977; (d) U. Kazmaier and C. Schneider, Tetra-
Ser. A, 1963, 16, 211–212. hedron Lett., 1998, 39, 817–818.
17 T. Kumamoto, H. Koshimo, D. Watanabe, Y. Matsumoto, 31 P. R. Blakemore, W. J. Cole, P. J. Kocienski and A. Morley,
K. Aoyama, K.-I. Harada, T. Ishikawa and Y. Mikami, Synlett, 1998, 26–28.
Heterocycles, 2009, 80, 281–288. 32 C. Marti and E. M. Carreira, J. Am. Chem. Soc., 2005, 127,
18 D. B. Hansen and M. M. Joullié, Tetrahedron: Asymmetry, 11505–11515.
2005, 16, 3963–3969. 33 M. Bakke, H. Ohta, U. Kazmaier and T. Sugai, Synthesis,
19 (2S,3R)-3-Methoxyphenylalanin: (a) H. Sugiyama, T. Shiori 1999, 1671–1677.
and F. Yokokawa, Tetrahedron Lett., 2002, 43, 3489–3492; 34 M. T. Gieseler and M. Kalesse, Org. Lett., 2014, 16, 548–551.
(b) S. Hajra and A. Karmakar, Tetrahedron: Asymmetry, 35 (a) U. Schmidt, A. Lieberknecht, U. Kazmaier, H. Griesser,
2004, 45, 3185–3188; (c) S. Hajra, A. Karmakar and G. Jung and J. Metzger, Synthesis, 1991, 49–55;
M. Bhowmick, Tetrahedron: Asymmetry, 2006, 17, 210–222. (b) U. Schmidt, H. Griesser, V. Leitenberger,
20 (2S,4R)-5-Hydroxyleucin: (a) Ref. 14a; (b) J. E. Tarver Jr., A. Lieberknecht, R. Mangold, R. Meyer and B. Riedl, Syn-
K. M. Terranova and M. M. Joullié, Tetrahedron, 2004, 60, thesis, 1992, 487–490.
10277–10284; (c) K. Sathish, G. P. K. Reddy, P. S. Mainkar 36 (a) M. Van den Berg, A. J. Minnaard, E. P. Schudde, J. Van
and S. Chandrasekhar, Tetrahedron: Asymmetry, 2011, 22, Esch, A. H. M. De Vries, J. G. De Vries and B. L. Feringa,
1568–1573. J. Am. Chem. Soc., 2000, 122, 11539–11540; (b) L. Panella,
21 (2S,3R)-2-Amino-3,5-dimethyl-4-hexensäure: (a) Ref. 14a; A. M. Aleixandre, G. J. Kruidhof, J. Robertus, B. L. Feringa,
(b) J. E. Tarver Jr. and M. M. Joullié, J. Org. Chem., 2004, 69, J. D. de Vries and A. J. Minnaard, J. Org. Chem., 2006, 71,
815–820. 2026–2036.
22 (2S,3R)-3-Hydroxytryptophane: (a) H. Sugiyama, 37 J. Deska, S. Hähn and U. Kazmaier, Org. Lett., 2011, 13,
F. Yokokawa, T. Aoyama and T. Shiori, Tetrahedron Lett., 3210–3213.
2001, 42, 7277–7208; (b) G. Della Sala, I. Izzo and 38 S. Futagawa, T. Inui and T. Shiba, Bull.Chem. Soc. Jpn.,
A. Spinella, Synlett, 2006, 1319–1322; (c) D. B. Hansen, 1973, 46, 3308–3310.
A. S. Lewis, S. J. Gavalas and M. M: Joullié, Tetrahedron: 39 M. T. Reetz, Angew. Chem., 1984, 96, 542–545, (Angew.
Asymmetry, 2006, 1, 15–21. Chem., Int. Ed., 1984, 23, 556–559).
23 U. Kazmaier, in Frontiers in Asymmetric Synthesis and 40 M. R. Luzung, C. A. Lewis and P. S. Baran, Angew. Chem.,
Application of alpha-Amino Acids, ed. V. A. Soloshonok 2009, 121, 7159–7163, (Angew. Chem., Int. Ed., 2009, 48,
and K. Izawa, ACS Books, Washington, 2009, 7025–7029).
pp. 157–176. 41 (a) M. Chakrabarty, T. Kundu and Y. Harigaya, Synth.
24 (a) U. Kazmaier, D. Schauß, M. Pohlman and S. Raddatz, Commun., 2006, 36, 2069–2077; (b) K. Ravinder,
Synthesis, 2000, 914–916; (b) M. Pohlman and U. Kazmaier, A. V. Reddy, K. C. Mahesh, M. Narasimhulu and
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 6036–6054 | 6053
View Article Online
Y. Venkateswarlu, Synth. Commun., 2007, 37, 281–287; 47 (a) E. J. Corey and A. Venkateswarlu, J. Am. Chem. Soc.,
(c) S. R. Dandepally and A. L. Williams, Tetrahedron Lett., 1972, 94, 6190–6191; (b) H. Wetter and K. Oertle, Tetra-
2009, 50, 1071–1074. hedron Lett., 1985, 26, 5515–5518; (c) M. Tandon and
42 E. Merkul, F. Klukas, D. Dorsch, U. Grädler, H. E. Greiner T. P. Begley, Synth. Commun., 1997, 27, 2953–2959.
and T. J. J. Müller, Org. Biomol. Chem., 2011, 9, 5129–5136. 48 A. Kawai, O. Hara, Y. Hamada and T. Shiori, Tetrahedron
43 P. Barbie and U. Kazmaier, Org. Biomol. Chem., 2015, 13, Lett., 1988, 29, 6331–6334.
9267–9275. 49 J. R. Parikh and W. v. E. Doering, J. Am. Chem. Soc., 1967,
44 K. F. Johnson, R. Van Zeeland and L. M. Stanley, Org. Lett., 89, 5505–5507.
2013, 15, 2798–2801. 50 C. McDonald, H. Holcomb, K. Kennedy, E. Kirkpatrick,
Published on 31 May 2016. Downloaded by National Taiwan University on 7/10/2020 2:17:27 PM.
45 Y. Ueda, M. Itoh, A. Sasaki and M. Sunagawa, J. Antibiot., T. Leathers and P. Vanemon, J. Org. Chem., 1989, 54, 1213–
2005, 58, 118–140. 1215.
46 (a) F. P. Miller, A. Metztger, M. A. Schade, B. A. Haag, 51 P. Li and J. C. Xu, J. Org. Chem., 2000, 65, 2951–2958.
A. Gavrushin and P. Knochel, Chem. – Eur. J., 2009, 15, 52 B. Springer, K. Lucke, R. Calligaris-Maibach, C. Ritter and
7192–7202; (b) A. Metzger, S. Berhardt, G. Manolikates and E. C. Böttger, J. Clin. Microbiol., 2009, 47, 1773–1780.
P. Knochel, Angew. Chem., 2010, 122, 4769–4773, (Angew. 53 E. Merkul, F. Klukas, D. Dorsch, U. Grädler, H. E. Greiner
Chem., Int Ed., 2010, 49, 4665–4668). and T. J. J. Müller, Org. Biomol. Chem., 2011, 9, 5129–5136.
6054 | Org. Biomol. Chem., 2016, 14, 6036–6054 This journal is © The Royal Society of Chemistry 2016